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COMPARATIVE STUDY OF ORBITAL DOPPLER PARAMETERS IN 
DIABETICS WITH RETINOPATHY AND DIABETICS/ HEALTHY CONTROLS 
WITHOUT RETINOPATHY 
1.INTRODUCTION 
Diabetes mellitus is one of the most common non communicable diseases 
globally. The prevalence of diabetes in our country is increasing. As the prevalence of 
diabetes is rising, the systemic complications that include retinopathy, nephropathy and 
neuropathy and involvement of cardiovascular system are also increasing. Diabetic 
retinopathy is a vascular disorder affecting the microvasculature of retina caused by 
changes in the retinal blood vessels. If untreated, it may lead to blindness. Therefore, if 
diagnosed and treated promptly, blindness is usually preventable. Color Doppler imaging 
is a new method that enables us to assess the orbital vasculature. It allows for 
simultaneous two dimensional anatomical and Doppler evaluation of hemodynamic 
characteristics of retinal artery 
[1].
 
For diagnosis of early changes in retinal blood flow in diabetes mellitus without 
retinopathy duplex color Doppler ultrasonography is the investigation of choice to assess 
the problem very quickly without any invasive procedures. Thus, this would be a 
beneficial tool for the ophthalmologist to assess and make quick decision about patient 
with impaired blood flow and to take necessary actions. They enable qualitative and 
quantitative assessment of the ophthalmic artery (OA) and its branches 
[2].
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The most frequently assessed vessels include: the ophthalmic artery, central retinal 
artery and central retinal vein. During examinations, vascular morphology is assessed and 
blood flow parameters are evaluated, such as: peak systolic velocity (PSV), end-diastolic 
velocity (EDV), resistance index (RI) and pulsatility index (PI). The measurements are 
taken with the use of a linear or sector probe with the frequency of over 7 MHz by 
applying it to the closed eyelid of a patient in the supine position. Pressure to the eyeball 
should be avoided. It is recommended to maintain uniform conditions of examinations, 
such as lighting in the room, size of the gate and a constant site for measurements in 
subsequent examinations 
[3].
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2.RATIONALE OF THE STUDY 
  Diabetic retinopathy (DR) is one of the leading causes of preventable blindness in India 
and worldwide. Annual retinal examinations are mandatory for all diabetic patients for 
early detection of DR as it can be asymptomatic. One of the main motivations for 
screening for DR is established efficacy of laser photocoagulation in preventing visual 
loss
[4].
 
     International disease severity scale for DR by Wilkinson is now used. This proposes 
five levels for grading of DR, based on risk of progression. Classification is worded as 
follows: none, mild non proliferative diabetic retinopathy (NPDR), moderate NPDR, 
severe NPDR or proliferative diabetic retinopathy (PDR).  Presence and severity of 
Diabetic Macular Edema (DME) by Wilkinson is classified separately. The progression 
from mild stages of DR to advanced stages occurs in a stepwise fashion. The earliest 
visible manifestation of DR is appearance of micro aneurysms in the retina. If glycemic 
control is inadequate, retinal vascular abnormalities like intraretinal hemorrhages and 
cotton wool spots can then occur. The clinical features of DR are summarized below. 
Signs of increasing ischemia are venous changes like beading and looping, intraretinal 
micro vascular abnormalities and increasing number of retinal hemorrhages and 
exudation. When these signs progress beyond certain defined thresholds, severe NPDR is 
diagnosed. The level of severe NPDR carries with it the most risk for progression to 
PDR
[4].
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Diabetic retinopathy is a vascular disorder affecting the microvasculature of retina.If 
untreated, it may lead to blindness which is usually preventable. Color Doppler imaging 
is a new method that enables us to assess the orbital vasculature with two dimensional 
anatomical and Doppler evaluations of hemodynamic characteristics of retinal artery. It is 
a useful tool when standard diagnostic procedures are difficult in the presence of cataract 
or hazy media. 
The utility of the doppler in south Indian popoulation has not been studied 
extensively.Thus our present study is planned to compare the orbital doppler parameters 
in diabetics with retinopathy and diabetics/ healthy controls without retinopathy in South 
Indian population and assess the utility of the Orbital Doppler study in Diabetic 
retinopathy. 
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3.REVIEW OF LITERATURE 
Embryology: The eyes begin to develop in 22-day embryo when optic grooves appear. 
The eyes are derived from four sources: 
 Neuroectoderm of the forebrain 
  Surface ectoderm of the head 
  Mesoderm between the previous two layers 
  Neural crest cells 
The neuroectoderm differentiates into the retina, posterior layers of iris, and optic nerve. 
The surface ectoderm forms the lens of the eye and the corneal epithelium. The 
mesoderm between the Neuroectoderm and surface ectoderm gives rise to the fibrous 
and vascular coats of the eye. Neural crest cells migrate into the mesenchyme and 
differentiate into the choroid, sclera, and corneal endothelium. 
          The first evidence of eye development is the appearance of optic grooves in the 
neural folds at the cranial end of the embryo .As the neural folds fuse to form the 
forebrain, the optic grooves evaginated (protruded) from the future diencephalon to form 
hollow diverticula (outpocketings) called optic vesicles, which project from the wall of 
the forebrain into the adjacent mesenchyme. The vesicles soon come in contact with the 
surface ectoderm. As the optic vesicles grow, their distal ends expand and their 
connections with the forebrain constrict to form hollow optic stalks. Concurrently, the 
surface ectoderm adjacent to the vesicles thickens to form lens placodes, which are the 
primordia of the lenses.  
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The lens placodes invaginate as they sink deep to the surface ectoderm, forming 
lens pits The edges of the lens pits approach each other and fuse to form spherical lens 
vesicles, which gradually lose their connection with the surface ectoderm. As the lens 
vesicles are developing, the optic vesicles invaginate to form double-walled optic cups, 
which consist of two layers that are connected to the developing brain by optic stalks. 
The optic cup becomes the retina, and the optic stalk becomes the optic nerve. The lens 
and part of the cornea develop from the ectoderm and mesoderm.  
Linear grooves (retinal fissures) develop on the ventral surface of the optic cups 
and along the optic stalks. The center of the optic cup, where the retinal fissure is deepest, 
forms the optic disc, where the neural retina is continuous with the optic stalk. The 
developing axons of the ganglion cells pass directly into the optic stalk and convert it 
into the optic nerve. The retinal fissures contain vascular mesenchyme from which 
hyaloid blood vessels develop. The hyaloid artery, a branch of the ophthalmic artery 
supplies the inner layer of the optic cup, the lens vesicle and the mesenchyme in the 
cavity of the optic cup. The hyaloid vein returns blood from these structures. As the 
edges of the retinal fissure fuse, the hyaloid vessels are enclosed within the primordial 
optic nerve. Distal parts of the hyaloid vessels eventually degenerate, but proximal parts 
of them persist as the central artery and vein of retina. 
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                            Fig.3.1Early stages of eye development 
  
Courtesy: THE DEVELOPING HUMAN, CLINICALLY ORIENTED EMBRYOLOGY  
A, Dorsal view of the cranial end of an embryo 
at approximately 22 days shows the optic 
grooves, which are the first indication of eye 
development. 
B, Transverse section of a neural fold shows the 
optic groove in it.  
C, Schematic drawing of the forebrain of an 
embryo at approximately 28 days shows its 
covering layers of mesenchyme and surface 
ectoderm.  
D, F, and H, Schematic sections of the 
developing eye show the successive stages in the 
development of the optic cup 
and lens vesicle.  
E, Lateral view of the brain of an embryo at 
approximately 32 days shows the external 
appearance of the optic cup. 
G, Transverse section of the optic stalk shows 
the retinal fissure and its contents. The edges of 
the retinal fissure are growing together, thereby 
completing the optic cup and enclosing the 
central artery and vein of the retina in the optic 
stalk and cup. 
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           Fig.3.2: Closure of the retinal fissure and formation of the optic nerve. 
 
Courtesy: THE DEVELOPING HUMAN, CLINICALLY ORIENTED EMBRYOLOGY 
The lumen of the optic stalk is gradually obliterated as axons of ganglion cells 
accumulate in the inner layer of the optic stalk as the optic nerve forms
[5].
 
A, C, and E, Views of the inferior 
surface of the optic cup and stalk show 
progressive stages in the closure of the 
retinal fissure.  
C1, Schematic drawing of a 
longitudinal section of a part of the 
optic cup and stalk shows the optic 
disc and axons of ganglion cells of the 
retina growing through the optic stalk 
to the brain. 
 B, D, and F, Transverse sections of 
the optic stalk show successive stages 
in the closure of the retinal fissure and 
formation of the optic nerve.  
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Anatomy of eyeball and its blood supply: 
Eyeball 
Each eyeball is a cystic structure kept distended by the pressure inside it. 
• Shape. Although, generally referred to as a globe, the eyeball is not a sphere but an 
oblate spheroid. 
• Poles. The central point on the maximal convexities of the anterior and posterior 
curvatures of the eyeball is called the anterior and posterior pole, respectively. 
• Equator of the eyeball lies at the mid plane between the two poles  
Coats of the eyeball 
The eyeball comprises three coats: outer (fibrous coat), middle (vascular coat) and inner 
(nervous coat). 
1. Fibrous coat. It is a dense strong wall which protects the intraocular contents. Anterior 
1/6th of this fibrous coat is transparent and is called cornea. 
Posterior 5/6th opaque part is called sclera. Cornea is set into the sclera like a watch 
glass. Junction of the cornea and sclera is called limbus. Conjunctiva is firmly attached at 
the limbus. 
2. Vascular coat (uveal tissue). It supplies nutrition to the various structures of the 
eyeball. It consists of three parts, from anterior to posterior, which are: iris, ciliary body 
and choroid. 
3. Nervous coat (retina). It is concerned with visual functions and projects to visual 
cortex through the visual pathway. 
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Segments and chambers of the eyeball 
The eyeball can be divided into two segments: anterior and posterior.  
1. Anterior segment: It includes crystalline lens (which is suspended from the ciliary 
body by zonules), and structures anterior to it, viz., iris, cornea and two aqueous humour-
filled spaces: anterior and posterior chambers. 
■Anterior chamber: It is bounded anteriorly by the back of cornea, and posteriorly by the 
anterior surface of iris and part of ciliary body. The anterior chamber is about 2.5 mm 
deep and is slightly shallower in hypermetropes and deeper in myopes.  
■Posterior chamber: It is a triangular space containing 0.06 ml of aqueous humour. It is 
bounded anteriorly by the posterior surface of iris and part of ciliary body, posteriorly by 
the crystalline lens and its zonules, and laterally by the ciliary body. 
2. Posterior segment. It includes the structures posterior to lens, viz., vitreous humour, 
retina, choroid and optic disc
[6]
 . 
 
  
Courtesy: Comprehensive ophthalmology 6
th
 edition, Khurana 
Fig.3.3: Gross anatomy of the eyeball 
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Vascular supply and drainage: 
The arterial supply to the eye is provided by several branches from the ophthalmic 
artery, which is derived from the internal carotid artery .These branches include the 
central retinal artery, the short and long posterior ciliary arteries, and the anterior ciliary 
arteries. Venous outflow from the eye is primarily via the vortex veins and the central 
retinal vein, which merge with the superior and inferior ophthalmic veins that drain into 
the cavernous sinus, the pterygoid venous plexus and the facial vein
[7]
 
 
Courtesy: Comprehensive ophthalmology 6
th
 edition, Khurana 
Fig.3.4: Ophthalmic artery and its branches 
The OA emerges through the optic foramen in the posterior orbit just lateral to the optic 
nerve. More anteriorly, the OA usually crosses over the optic nerve and continues into the 
anteromedial orbit. The central retinal, long and short ciliary, lacrimal, supraorbital, and 
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supratrochlear arteries are all branches of the OA that can be visualized in most normal 
orbits. The OA can be consistently located with color flow imaging by scanning medial 
to the optic nerve approximately 15 mm posterior to the globe. The central retinal artery 
(CRA) and central retinal vein (CRV) nourish the inner two-thirds of the retina. The 
artery and vein parallel one another in the center of the distal optic nerve 
[8].
 
 
Fig.3.5: Blood supply of eyeball 
 
 
Courtesy: Comprehensive ophthalmology 6
th
 edition, Khurana 
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Diabetes Mellitus: 
Diabetes mellitus comprises of a group of chronic metabolic disorders involving the 
principal metabolic fuels, carbohydrates, fats as well as proteins. The disorder results 
from absolute or relative deficiency in insulin secretion often along with defect in insulin 
action. The syndrome of diabetes mellitus is characterized by chronic hyperglycemia 
(blood glucose above defined limits) with or without glucosuria and a tendency to 
develop ketoacidosis. Polyuria, polydipsia, asthenia and weight loss, the cardinal 
symptoms of severe hyperglycemia, may not be present in a proportion of cases. There is 
an increased susceptibility to bacterial and fungal infection. In course of time, prolonged  
hyperglycemia and associated metabolic aberrations result in tissue toxicity manifested as 
accelerated atherosclerosis, renoretinal microangiopathy and neuropathy leading to a 
variety of vascular, neurological and focal complications
[9].
 
Epidemiology: 
Currently Diabetes Mellitus has emerged as a challenge worldwide in epidemic 
proportions. According to the WHO estimates, by the year 2030, the number of people 
affected with DM will increase to 360 million 
[1]
. Changes in life style, dietary pattern, 
physical inactivity and obesity are responsible for increasing the prevalence of diabetes 
mellitus into the developing countries which is no longer a disease of developed 
countries. All DM patients are at risk of developing diabetic retinopathy (DR)
[10].
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India, a country experiencing rapid socioeconomic progress and urbanization, carries a 
considerable share of the global diabetes burden. Studies in different parts of India have 
demonstrated an escalating prevalence of diabetes not only in urban populations, but also 
in rural populations as a result of the urbanization of lifestyle parameters. The prevalence 
of prediabetes is also high. Recent studies have shown a rapid conversion of impaired 
glucose tolerance to diabetes in the southern states of India, where the prevalence of 
diabetes among adults has reached approximately 20% in urban populations and 
approximately 10% in rural populations. Because of the considerable disparity in the 
availability and affordability of diabetes care, as well as low awareness of the disease, the 
glycemic outcome in treated patients is far from ideal. Lower age at onset and a lack of 
good glycemic control are likely to increase the occurrence of vascular complications. 
The economic burden of treating diabetes and its complications is considerable
[11].
 
Diagnosis: 
Blood glucose is normally maintained in a very narrow range, usually 70 to 120 mg/dL. 
According to American Diabetes Association (ADA) and the World Health Organization 
(WHO), diagnostic criteria for diabetes include the following: 
1. A fasting plasma glucose greater than or equal to 126 mg/dL, and/or 
2. A random plasma glucose greater than or equal to 200 mg/dL (in a patient with classic 
hyperglycemic signs), and/or 
3. A 2-hour plasma glucose greater than or equal to 200 mg/dL during an oral glucose 
tolerance test with a loading dose of 75 gm, and/or 
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4.  A glycated hemoglobin (HbA1c) level greater than or equal to 6.5%  
All tests, except the random blood glucose test in a patient with classic hyperglycemic 
signs, need to be repeated and confirmed on a separate day. Of note, many acute 
conditions associated with stress, such as severe infections, burns, or trauma, can lead to 
transient hyperglycemia due to secretion of hormones such as catecholamines and 
cortisol that oppose the effects of insulin. The diagnosis of diabetes requires persistence 
of hyperglycemia following resolution of the acute illness. 
Impaired glucose tolerance (prediabetes) is defined as: 
1. A fasting plasma glucose between 100 and 125 mg/dL (impaired fasting glucose) 
and/or 
2. A 2-hour plasma glucose between 140 and 199 mg/dL during an oral glucose tolerance 
test and/or 
3. HbA1c level between 5.7% and 6.4% 
[12].
 
Complications:  
The complications related to diabetes include acute, life-threatening metabolic 
disturbances and chronic complications which predominantly involve small and large 
blood vessels and the nervous system. The risk of vascular complications increases with 
the duration of the disease. Diabetic retinopathy is the most common microangiopathic 
complication, specific for type I and II diabetes
[13].
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Courtesy: Robbins Pathology, 10th edition 
Fig.3.6: Long term complications of Diabetes Mellitus 
Pathogenesis of Diabetic microangiopathy: 
One of the most consistent morphologic features of diabetes is diffuse thickening 
of basement membranes. The thickening is most evident in the capillaries of the skin, 
skeletal muscle, retina, renal glomeruli, and renal medulla. However, it also may be seen 
in nonvascular structures such as renal tubules, the Bowman capsule, peripheral nerves, 
and placenta. By both light and electron microscopy, the basal lamina separating 
parenchymal or endothelial cells from the surrounding tissue is markedly thickened by 
concentric layers of hyaline material composed predominantly of type IV collagen. Of 
note, despite the increase in the thickness of basement membranes, diabetic capillaries are 
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leaky, leading to extravasation of plasma proteins. The microangiopathy underlies the 
development of diabetic nephropathy, retinopathy and some forms of neuropathy. The 
ocular involvement may take the form of retinopathy, cataract formation, or glaucoma. 
Retinopathy, the most common pattern, consists of a constellation of changes that 
together are considered by many ophthalmologists to be virtually diagnostic of the 
disease. The lesion in the retina takes two forms: non proliferative retinopathy and 
proliferative retinopathy.  
Non proliferative retinopathy includes intraretinal or preretinal hemorrhages, 
retinal exudates, micro aneurysms, venous dilations, edema, and, most importantly, 
thickening of the retinal capillaries (microangiopathy). The retinal exudates can be “soft” 
(micro infarcts) or “hard” (deposits of plasma proteins and lipids). The micro aneurysms 
are discrete saccular dilatations of retinal choroidal capillaries that appear through the 
ophthalmoscope as small red dots. Dilatations tend to occur at focal points of weakening, 
resulting from loss of pericytes. Retinal edema presumably results from excessive 
capillary permeability. Underlying all of these changes is the microangiopathy, which is 
thought to lead to loss of capillary pericytes and hence to focal weakening of capillary 
structure  
Proliferative retinopathy is a process of neovascularization and fibrosis. This 
lesion leads to serious consequences, including blindness, especially if it involves the 
macula. Vitreous hemorrhages may result from the rupture of newly formed capillaries; 
the subsequent organization of the hemorrhage can pull the retina off its substratum 
(retinal detachment) 
[12].
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Courtesy: Comprehensive Opthalmology 6
th
 edition ,Khurana 
           Fig.3.7: Flowchart depicting pathogenesis of diabetic retinopathy 
 
Risk factors 
1. Duration of diabetes is the most important determining factor. After 10 years, 20% of 
type I and 25% of type II diabetics develop retinopathy. After 20 years, 90% of type I and 
60% of type II diabetics develop retinopathy. After 30 years, 95% of both type I and type 
II diabetics develop retinopathy. 
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2. Age of onset of diabetes also act as a risk factor. The risk of retinopathy in a child 
with onset of diabetes at the age of 2 years is negligible for the first 10 years. After onset 
of puberty, age of onset is not a risk factor. 
3. Sex. Incidence is more in females than males (4:3). 
4. Poor metabolic control is less important than duration, but is nevertheless relevant to 
the development and progression of DR. 
5. Heredity. It is transmitted as a recessive trait without sex linkage. The effect of 
heredity is more on the proliferative retinopathy. 
6. Pregnancy may accelerate the changes of diabetic retinopathy. 
7. Hypertension, when associated, may also accentuate the changes of diabetic 
retinopathy. 
8. Other risk factors include smoking, obesity, anemia and hyperlipidemia
 [14]
. 
The Early Treatment Diabetic Retinopathy Study severity scale based on modified Airlie 
House classification of DR is the gold standard for grading DR
 [15]
. It is based on seven 
fields stereo color photographs. This grading system has been used for several landmark 
clinical trials. The ETDRS classification is difficult to use in clinical settings as it is time 
consuming requires correlations with standard photographs and needs skilled 
photographers and trained graders. Hence, International disease severity scale for DR by 
Wilkinson is now used
 [16]
.This proposes five levels for grading of DR, based on risk of 
progression. 
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Classification is worded as follows:  
A. None 
B. Mild non proliferative diabetic retinopathy  
C. Moderate non proliferative diabetic retinopathy 
D. Severe non proliferative diabetic retinopathy 
E. Proliferative diabetic retinopathy 
Table.3.1:International disease severity scale for diabetic retinopathy by Wilkinson 
 
 
 
 
Fig.3.8: Mild non-proliferative diabetic retinopathy with microaneurysms 
 
 
 
Courtesy: RSSDI TEXTBOOK OF DIABETES MELLITUS 
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Fig.3.9: Moderate non-proliferative diabetic retinopathy with microaneurysms 
and cotton wool spots 
 
 
 
 
Fig.3.10: Severe non-proliferative diabetic retinopathy with venous looping and blot 
hemorrhages 
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Fig.3.11:Proliferative diabetic retinopathy 
 
Table.3.2:Presence and severity of DME by Wilkinson is classified separately. 
 
              Courtesy: RSSDI TEXTBOOK OF DIABETES MELLITUS 
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Fig.3.12:  Mild diabetic macular edema 
 
 
 
The progression from mild stages of DR to advanced stages occurs in a stepwise fashion
 
[17]
.The earliest visible manifestation of DR is appearance of microaneurysms in the 
retina. If glycemic control is inadequate, retinal vascular abnormalities like intraretinal 
hemorrhages and cotton wool spots can then occur.  
The clinical signs of DR are summarized below. Signs of increasing ischemia are venous 
changes like beading and looping, intraretinal micro vascular abnormalities and 
increasing number of retinal hemorrhages and exudation. When these signs progress 
beyond certain defined thresholds, severe NPDR is diagnosed
 [17]
.The level of severe 
NPDR carries with it the most risk for progression to PDR. 
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Table.3.3: clinical signs of diabetic retinopathy 
 
Courtesy: RSSDI textbook of diabetes mellitus 
 
The following methods are used to assess diabetic retinopathy: ophthalmoscopic 
evaluation of the fundus, examination through a slit lamp with the application of lenses, 
retinal photography, and supplemental examinations, such as: fluorescein angiography, 
optical coherence tomography of the retina and B-mode ultrasound imaging 
[18,19]
. 
Direct ophthalmoscopy: 
  It produces high magnification (15×) and is very useful in identifying microaneurysms, 
retinal hemorrhages, hard exudates, cotton wool spots and new vessels. 
Indirect ophthalmoscopy: 
      It aids to assess the periphery of the fundus. 
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 Slit lamp biomicroscopy with contact lens: 
 It is very helpful to assess Diabetic macular edema (DME). It is important to detect 
DME in the assessment of DR as this is the most frequent cause of decreased vision from 
retinopathy. 
Retinal Color Photography: 
It is useful to document retinal lesions. It is more reproducible than clinical examination 
and useful in research studies. It helps to document progression of DR and response of 
treatment. 
Fundus Fluorescein Angiography (FFA): 
It involves photographic surveillance of passage of fluorescein through the retinal and 
choroidal circulation following intravenous injection. 5 ml of 10% fluorescein dye is 
injected into the vein and after an arm retina time of 11–15 seconds and serial angiogram 
pictures at different phases are taken using digital retinal camera. FFA is indicated in 
patients with DR to assess areas of leakage and also for macular ischemia (where laser 
has to be avoided). In severe NPDR, it helps to assess risk of developing PDR. Patients 
with unexplained visual loss will also be benefited with FFA
 [20]
. 
Optical Coherence Tomography (OCT): 
It is a non-invasive, non-contact imaging system which provides high resolution 
cross sectional images of retina and optic nerve. OCT uses light instead of sound waves. 
It is indicated to quantify the retinal thickness in the different areas of the macula, 
identify cystic spaces in the macula, identify macular holes, neurosensory detachment 
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and vitreomacular traction. It helps to assess the response of treatment like laser and 
intravitreal injections and in analysis of optic nerve head and retinal nerve fiber layer
 [21]
. 
B-Scan Ultrasound: 
It helps to assess the presence of vitreous hemorrhage and retinal detachment in diabetic 
patients with opaque media. 
Colour Doppler Imaging Of Orbital vessels: 
Colour Doppler imaging (CDI) is a useful diagnostic tool in evaluating ocular and orbital 
diseases. Based on its capacity to combine two-dimensional B-mode image and 
functional blood flow analysis, this non-invasive method is suitable to study vascular 
abnormalities involving the central retinal artery, central retinal vein, posterior ciliary 
arteries, ophthalmic artery, and superior ophthalmic vein. It is also applied to assess 
hemodynamic changes in orbital vasculature. Furthermore, in comparison to other 
imaging methods such as computerized tomography (CT) and magnetic resonance 
imaging (MRI), CDI has the advantage of not using radiation. Ease of use and portability 
of equipment are also distinct advantages with CDI. Most importantly, CDI offers the 
capability of visualizing ocular and orbital vessels not frequently assessed by other 
methods
 [22]
. 
Color Doppler imaging is a non-invasive method .The most frequently assessed vessels 
includes the ophthalmic artery, central retinal vein and artery, and the posterior ciliary 
arteries. The analysis of hemodynamic alterations in the retrobulbar vessels may deliver 
important information concerning circulation in diabetes and  the changes observed in 
blood flow in the vessels with progression of diabetic retinopathy of the eyeball
[3].
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Colour Doppler Imaging: background and physical considerations 
The Doppler effect is the property of sound waves or electromagnetic waves to 
undergo changes in their velocity of propagation by the movement of a given reflector. 
This is a physical principle first described by Johann Christian Doppler, an Austrian 
scientist in 1842
[23]
.Doppler ultrasonography is based on ultrasound wave reflection by a 
reflector (e.g. blood column), which moves at a given velocity in one direction in 
reference to a transducer. The frequency of the emitted sound is altered by the velocity of 
blood particles. This frequency is increased when the blood flow is moving towards the 
transducer and decreases when blood moves away. Calculation of the magnitude of 
reflected sound yields an estimate of blood flow; the faster the blood flow (reflector), the 
greater the difference between the reflected and emitted frequencies (Doppler shift – ΔF), 
as demonstrated by the formula, 
∆F = 2VF0 /C, which can be rearranged to give: 
V   =   ∆FC /2F0 where, ΔF is frequency change, V is velocity of the reflector, F0 is 
sound source frequency, and C is the speed of sound in tissue .This equation is valid 
when transducer and reflector are parallel. Although orbital vessels are frequently parallel 
to the ultrasound beam, angle correction should be used when needed. Newer versions of 
the equipment automatically adjust for angle correction in the velocity calculations. 
Improvements in CDI techniques have tried to overcome limitations, such as angle 
dependence and difficulty in separating background noise from true flow in slow-flow 
states. Power Doppler sonography is able to evaluate low blood flow and has relative 
angle independence thereby offering superior depiction of tissue perfusion
[24,25].Power 
Doppler sonography may be particularly valuable in assessing small vasculature of the 
eye. Doppler information can be combined with gray-scale image ultrasound to provide 
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two-dimensional imaging (B-scan) and blood flow calculation (velocity and direction). 
Color duplex-scanning is obtained by representation of relative mean velocity of 
reflectors and emitters in a given area. Sound reflection signals are frequently displayed 
with color tone, saturation, and brightness as a function of their velocity. In addition, real-
time blood flow assessment during the cardiac cycle is also possible (Doppler spectral 
analysis). 
Table.3.4: Commonly used techniques in Doppler imaging. 
 
          Courtesy: Opthalmic Ultrasonography, Elsevier 
Examination technique and device parameters: 
CDI examination of the globe and orbit is performed with the patient in the supine 
position, through closed eyelids. The transducer is placed on the eyelid using ophthalmic 
solution or acoustic gel. Care should be taken to avoid globe pressure that can lead to 
artifactual decrease in blood flow velocity. For ophthalmic applications, linear 
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transducers with sound frequencies ranging from 7.5 to 15 MHz are preferred. Horizontal 
and vertical grayscale imaging can be performed first in order to assess the entire ocular 
and orbital anatomy. 
Color flow information is used to depict the major vascular structures in the orbit, which 
can be displayed in either blue or red. Color parameters can be subjectively assigned 
regarding the direction of the blood flow with respect to the transducer. In general, the 
flow moving towards the transducer is displayed in red, and away from it, is showed in 
blue. 
Orbital vessels are frequently parallel to the sound beam, thus, for the majority of the 
time arteries are displayed in red and veins in blue. A pulsed Doppler spectral analysis is 
also obtained to distinguish between arterial and venous flow. CDI application in 
ophthalmology dates from the late 1980s. It is applied to evaluate several ocular and 
orbital diseases 
[26-38]
 .Several studies have demonstrated CDI velocities of orbital vessels 
in normal eyes with relatively good reproducibility [28, 29, 33, 35, 38-41]. 
TECHNIQUE: 
Equipment: 
A 7.5-MHz vector transducer with a 14-mm-wide face has an appropriate footprint and 
adequate depth of penetration for most examinations. 
A 10-MHz probe gives better resolution in the near field and may be useful in evaluating 
abnormalities in the globe. A stand-off can be used to evaluate more anterior structures. 
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Examination Method: 
Ultrasonogram (USG) examination of the orbit is performed through the closed eyelid 
with the patient supine. Contact lenses are removed prior to the examination. As little 
pressure as possible should be exerted on the globe to avoid inaccurate vascular 
recordings and patient discomfort; stabilizing the transducer with fingers on the forehead 
or cheek is helpful. The patient is instructed to keep the eyes closed and must be able to 
remain reasonably still for the examination. 
                   
Fig.3.13: USG technique. Photograph from a standard examination shows scanning being 
performed. 
 
Sterile USG coupling gel has been applied to the eyelid. Gray-scale imaging is performed 
first to obtain an overview of the anatomy in the orbit. Imaging in several planes is 
possible. Colour flow information is then used to identify the major vascular structures in 
the orbit, as well as to assess the vascularity of any detected abnormalities. The standard 
examination takes approximately 10-15 minutes per eye. Color flow images were 
obtained. Pulsed Doppler recordings can then be obtained. A small Doppler gate is 
necessary to provide accurate and reproducible wave forms. 
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Angle correction was applied to the pulsed Doppler recordings to minimize errors in the 
measured velocities. The peak systolic (PSV) and end-diastolic (EDV) velocities are 
measured in the ophthalmic artery, central retinal artery, and in the central retinal vein. 
The measurements to calculate vascular resistance (expressed by the resistivity index and 
pulsatile index) using the following formula: 
Resistivity index = (PSV-EDV)/PSV 
[42]
 and 
Pulsatile index = (PSV-EDV)/Vmean 
Where Vmean = 1/3 (PSV-EDV) +EDV 
[43]
, in all patients.  
Signals from the ophthalmic artery can be located in the medial section of an eyeball, 
superior to the optic nerve, just lateral to and abutting the visible hypo echoic stripe 
representing the nerve. The central retinal artery originates from the ophthalmic artery 
and can be found anterior to the optic nerve, around 7.5 mm behind the ocular bulb.  
A specific finding of the blood flow in the central retinal vein is its pulsatile character. As 
the velocity wave in a  vein is not in direct relation to the cardiac systole and diastole, the 
blood flow parameters in this vessel are usually described as maximum (V max) and 
minimum blood velocity (Vmin) generally. The Velocity maximum and Velocity 
minimum in the central retinal vein is represented as the Peak systolic velocity and End 
diastolic velocity respectively. 
Safety Issues: 
There is several important safety issues related to color Doppler imaging of the orbit. The 
power output from the ultrasound transducer during pulsed Doppler examination at the 
settings most commonly used is 71 mW/cm2, which exceeds the limit of 17 mW/cm2 set 
 32 
by the Food and Drug Administration for ophthalmic examinations but is within the 100 
mW/cm2 guidelines suggested by the American Institute for Ultrasound in Medicine. For 
this reason, the amount of time spent obtaining pulsed Doppler recordings should be 
minimized. If color Doppler imaging is necessary, it should be performed with minimal 
pressure on the globe and for the shortest possible time 
[8]
. 
Gray-Scale US Anatomy: The normal anatomy of the orbit as seen on gray-scale US. 
The lens, iris, and ciliary body can be seen routinely within the otherwise anechoic globe. 
The optic nerve-optic nerve sheath complex appears as a hypo echoic stripe posterior to 
the globe that extends to the orbital apex. The retrobulbar fat is hyper echoic, and the 
extra ocular muscles are slightly hypo echoic bundles that course from the globe to the 
orbital apex. The lacrimal gland can often be identified in the superolateral orbit. 
 
Fig.3.14: Normal gray-scale US anatomy. (a) Transverse gray-scale US image through the orbit 
demonstrates the anechoic globe (G) anteriorly. The hypo echoic optic nerve-optic nerve sheath complex 
(N) extends posteriorly from the globe. Retrobulbar fat (F), extra ocular muscles (small arrows), and the 
orbital wall (large arrows) are visible. (B) Transverse gray-scale US image through the globe 
demonstrates the vitreous body (V), retina and sclera (black arrows), optic nerve-optic nerve sheath 
complex (N), lens (L), anterior chamber (A), ciliary body (arrowhead), iris (white arrow), and cornea (C). 
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Table.3.4: Normal blood flow velocity (cm/sec) in orbital vessels. 
 
 
 
Fig.3.15: Color Doppler imaging parameters in normal subjects. CDI of the orbit 
using 5–12 MHz linear transducer showing CRA & CRV 
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The waveform of the CRA is characteristic of a low-resistance system. It consists of a 
rounded systolic peak followed by a slow decline in velocity, with flow continuing 
throughout diastole. The waveform of the CRV is obtained in the same spectrum as that 
of the CRA. It consists of relatively low, continuous flow in the opposite direction 
relative to arterial flow. 
 
Fig.3.16:CRA and CRV. (a) Transverse 
color flow image demonstrates the normal 
CRA and CRV (arrow) in the center of the 
distal optic nerve (N). 
(b) Pulsed Doppler recording of typical 
waveforms from the central retinal vessels 
shows the arterial waveform above the zero 
axis and the venous waveform below the 
zero axis. Note the rounded systolic peak 
(arrow) and the continuous flow during 
diastole in the arterial waveform. The 
venous flow is low and continuous, with a 
peak in flow velocity (arrowhead) a fixed 
time after the systolic peak. 
 
Fig.3.17: Spectral Doppler analysis in 
normal subjects. Pulse waveform shows 
pulsatile arterial component above the 
horizontal line and laminar venous flow 
below the horizontal line. Peak systolic 
velocity (PSV) of the CRA: 15.13 cm/s. 
Resistance index (RI) of the CRA: 0.64 (A) 
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Fig.3.18: Ophthalmic artery .A systolic peak, dicrotic incisura, slightly diastolic flow 
declination, PSV: 42.28 cm/s, and RI: 0.77 are observed 
 
 
  
The waveform of the OA is typical for a relatively high-resistance artery. There is a sharp 
initial peak followed by an incisura and relatively little flow during diastole.. 
 
 
Fig.3.19:OA. (a) Transverse color flow 
image demonstrates the normal location 
of the OA (arrow) medial to the optic 
nerve (N) in the midorbit. G =globe. (b) 
Pulsed Doppler recording of the normal 
OA waveform shows a sharp systolic peak 
(arrowhead),a dicrotic notch (arrow), and 
relatively little flow in diastole. On all 
pulsed Doppler images, scale at side of 
image is in meters per second and scale at 
top of image is in seconds. 
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Previous similar studies: 
The literature says the existence of hemodynamic alterations in the vessels of the eyeball 
observed in patients with Diabetes mellitus .However, some authors report different 
results. This may be a due to assessment of vascular changes in various stages of diabetes 
mellitus and different criteria of patient selection. This heterogeneity concerns the types 
of diabetes mellitus and the duration, the status of diabetic retinopathy, co morbid 
conditions, associated ocular lesions and Doppler parameters. The main component in 
these observations is the assessment of Doppler flow parameters and their significance in 
the prognosis of diabetic retinopathy and its monitoring. 
Goebel et al
 [44]
 were the first ones to show a high sensitivity of this method in monitoring 
hemodynamic changes in patients with diabetic retinopathy. They compared patients with 
simple, non proliferative and proliferative retinopathy.  They found a significant decrease 
in PSV and EDV in the CRA as compared to healthy normal controls. A decrease in 
blood flow velocity in the retrobulbar vessels was observed in all groups, which 
correlated with the progression of diabetic retinopathy. No significant difference in 
Doppler flow parameters in the OA and PCAs were observed. They did not calculate the 
resistivity index. 
Kawagishi et al
.[45] 
found the decrease in PSV and EDV in the CRA. They found the 
changes in the CRA before clinical features of Diabetic retinopathy appeared. The RI was 
found to be elevated and correlated with the blood glucose level. 
 37 
Güven et al.
[46] 
reached the same results wherein they noted reduction  in PSV in the 
CRA in patients with NPDR and PDR as well as in patients following retinal laser pan 
photocoagulation. Here, the RI index was not calculated either and there was no 
significant differences in the flow velocities of OA and PCAs. 
Mendivil et al.
[47]
 noticed a significant reduction in PSV and EDV in the OA and CRA in 
patients with proliferative retinopathy compared to healthy normal individuals. No 
velocity disturbances were noted in the PCAs. They 
[48]
 also studied the influence of laser 
pan photocoagulation on blood flow velocity and found that retinal photocoagulation 
caused a significant reduction in the flow velocity of OA, CRA and CRV. These 
parameters did not change in a significant manner in a period of one year of follow-up. 
Arai et al.
[49] 
emphasized the significance of the RI index in the CRA and OA. According 
to them, it is a more sensitive Doppler parameter for predicting the severity of diabetic 
retinopathy than Doppler flow velocity measurements in these vessels. Greater vascular 
resistance may be seen  prior to retinopathy. They claimed that measurements in the CRA 
are more significant for hemodynamic alteration assessment in diabetes than 
measurements in the OA. The PSV and EDV values in the CRA were significantly lower 
in  both diabetics with retinopathy and without retinopathy. The differences noticed were 
dependent on the severity of retinopathy. CRA is more sensitive to auto regulation 
disorders which show changes even before any findings noted in the fundus. PSV in the 
OA showed no differences between the groups. 
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Evans et al
[50] 
did their studies in hyperoxic conditions in normal healthy individuals and 
in diabetic patients without or with minimal retinopathy changes  in the ocular fundus. 
Both study groups were examined during regular normal breathing and after oxygen 
saturation. In hyperoxic conditions, the EDV and RI changed in a significant manner in 
healthy individuals as EDV decreased and RI increased. In contrast, the diabetic patients 
examined under hyperoxic conditions showed increased EDV in the CRA and decreased 
RI compared to the normal control group. No statistically significant changes in the OA 
found in the healthy controls. 
Ino-ue et al.
[51] 
studied
 
 changes in blood flow velocities in the OA in patients with ocular 
ischemic syndrome and with simple as well as proliferative diabetic retinopathy. The 
persons with diabetic retinopathy presented lower EDV and higher PI values when 
compared with the control group, and persons with ocular ischemic syndrome and 
diabetes showed significantly reduced systolic and diastolic velocities and increased 
pulsatility indices. There were no significant differences between the groups and no 
relation was noticed between the flow velocity of orbital vessels and progression of 
diabetic retinopathy. 
MacKinnon et al.
[52]
 studied flow velocities in the OA and CRA as well as the RI index in 
three groups of patients: without diabetic retinopathy or with simple retinopathy, with 
preproliferative or proliferative lesions and in healthy normal controls. In the group of 
patients with preproliferative and proliferative retinopathy, PSV and EDV in the CRA 
were significantly reduced than in patients without lesions or with simple retinopathy. In 
 39 
comparison with the control group, the RI index was considerably increased in the OA 
and decreased in the CRA. In the OA, however, no difference in velocities was noted 
between the examined groups. 
Dimitrova et al
[53]
in their study compared the results of blood flow measurements in 
patients with simple retinopathy following 21 months from the primary examination and 
assessed the influence of the disease progression on hemodynamic changes. After this 
period of time, they observed no changes in the flow parameters were in the CRA and 
ciliary arteries. The authors suggest that, with the progression of diabetic retinopathy, 
initial lesions develop in the central retinal vein. 
Krepler et al.
[54]
studied the effect of vitrectomy done in patients with diabetic retinopathy 
on the ocular blood flow. The mean flow velocity in the CRA and PCAs decreased in a 
significant manner, and the RI value reduced in the CRA with no change in the PCAs 
after vitrectomy. The results showed that the vitrectomy may cause a reduction in the 
ocular blood flow. 
Sullu et al
 [55]
 performed similar studies and assessed orbital blood flow parameters in the 
first and sixth months after the vitrectomy procedure. A significant decrease of the 
Resistivity index in the CRA was found after the procedure. 
Gracner
 [56]
 observed the Doppler parameters in the OA, CRA and PCAs on various 
stages of diabetic retinopathy development and showed a significant increase in PSV in 
the Opthalmic artery with advanced preproliferative and proliferative lesions as well as a 
decrease in PSV and EDV in the Central retinal artery when compared to the control 
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group. They also noted a reduction in EDV in the PCAs. The RI index in the Opthalmic 
Artery and Central retinal artery did not change in a significant manner, but increased in 
the PCAs. The author suggested that the results may be useful in assessing the 
progression of the disease. 
Kraśnicki et al.[57] assessed blood flow velocities in the orbital vessels  in patients with 
type II diabetes in a group without lesions in the ocular fundus and in another group with 
the presence of non-proliferative retinopathy lesions. They found significantly lower PSV 
and EDV values in the OA in both groups compared to healthy controls. The RI did not 
alter in a statistically significant manner. In the CRA, PSV and EDV were significantly 
lower only in the group with more severe diabetic retinopathy lesions. The RI was 
significantly higher in patients with more advanced retinopathy lesions. In the PCAs, the 
significant difference was observed only in the PSV in the group of patients with non-
proliferative diabetic retinopathy group. The authors stressed the role of Colour Doppler 
ultrasonography and the influence of decreased blood flow parameters in the CRA and 
ciliary arteries on the development of retinopathy. 
Yilmaz Ovali et al.
[58]
 assessed the orbital vessels in pediatric patients with type I 
diabetes but without retinopathy and detected alterations in the blood flow parameters in 
the OA and CRA when compared with healthy peers. In patients with diabetes mellitus 
for more than 5 years, EDV in the OA was significantly higher and the RI was lower. The 
RI in the CRA increased in patients with higher levels of microalbuminuria. The 
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examination revealed early lesions in the OA that were not as significant as reported by 
other studies
 [45, 49, 52]
. 
Modrzejewska et al
[59] 
assessed blood flow parameters of the vessels in the eyeball and 
their relation to the blood lipid values in the group of young patients with type I diabetes  
who  had initial vascular lesions in the fundus. The study showed a decrease in blood 
flow parameters when the vascular lesions in the ocular fundus were at their initial stage. 
Peak Systolic Velocity, Mean Velocity (MV) and Resistivity Index in the CRA as well as 
PSV, MV and PI in the temporal posterior ciliary arteries (TPCAs) values were found to 
be decreased. The differences in total cholesterol level, HDL, LDL cholesterol and 
apolipoproteins (ApoB) were associated with blood flow resistance alterations, mainly in 
the OA. They suggested that the effect of lipid disorders on the risk of retinal ischemia in 
young patients with type I diabetes mellitus may be significant. 
Dimitrova et al. 
[60]
 studied the relation between diabetic retinopathy and arterial 
hypertension on the basis of flow analyses in the central retinal vein and artery in four 
groups of patients. PSV and EDV velocities were the highest in the group of patients 
without retinopathy and hypertension, as well as in patients without retinopathy but with 
systemic hypertension. The Pourcelot index in the CRV was significantly lower in both 
groups. A significant relation was noted between systemic hypertension, status of 
diabetic retinopathy and PSV in the CRA. 
Lockhart et al.
[61]
used novel techniques of spectral Doppler analysis for a quantitative 
assessment of blood flow changes in the orbital vessels and carotid arteries .The aim of 
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the study was to study whether it is possible to detect subclinical circulation disorders in 
patients with uncomplicated Type I diabetes mellitus. The authors identified measurable 
differences in blood flow velocities much earlier to the development of profound 
retinopathy. 
Pemp et al.
[62] 
studied the relation between blood flow parameters in the CRA measured 
in a color Doppler examination and blood flow parameters in the CRA assessed with a 
laser Doppler flow meter with regard to the caliber of the vessel. The groups included 
patients with type I DM with mild retinopathy and without it, and they were compared 
with normal individuals. The patients with diabetes showed greater vascular diameter of 
the CRA, but no significant blood flow parameter differences were noticed. The authors 
recommended caution in interpreting the results as the use of color Doppler sonography 
does not provide information on the vascular diameters.   
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4.AIM OF THE STUDY 
 
The Aim of this study is to compare orbital vessel Doppler indices in diabetics with 
retinopathy and diabetics/healthy controls without retinopathy using the color Doppler 
sonography. The Peak Systolic Velocity, End Diastolic Velocity, Pulsatility Index and 
Resistivity Index are measured in Opthalmic artery, Central retinal artery and Central 
retinal vein in the three groups and compared. 
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5.METHODOLOGY 
STUDY CENTRE: Barnard Institute of Radiology, 
   Madras Medical College, 
                                 Rajiv Gandhi Govt General Hospital, Chennai 
STUDY PERIOD: JUNE 2017 – MAY 2018          
NUMBER OF HEALTHY CONROLS: 90 
NUMBER OF DIABETIC PATIENTS WITHOUT RETINOPATHY: 68 
NUMBER OF PATIENTS WITH RETINOPATHY: 55 
DURATION OF STUDY:  ONE YEAR  
STUDY DESIGN: Prospective study 
INCLUSION CRITERIA : 
 Age between 20 and 80 years, both sexes. 
 Cases with non proliferative diabetic retinopathy. 
 Diabetics without retinopathy 
 Non-diabetic healthy controls were included in the study. 
EXCLUSION CRITERIA: Exclusion criteria were  
 Previous laser photocoagulation 
 Proliferative diabetic retinopathy 
 Any disease or anomaly of the eye, which may affect blood flow velocity, such as 
ocular   inflammation, systemic diseases like hypertension, Non-diabetic vascular 
disease. 
 Trauma 
 Lactating and pregnant females whatever the gestational age. 
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METHODOLOGY: 
This prospective study was performed after obtaining clearance from our Institutional 
Ethics Committee and institutional informed consent guidelines were observed.  The 
patients were screened using the drawn inclusion/ exclusion criteria. Relevant entries in 
the proforma for each patient were made after reviewing his/her case sheet & previous 
medical records.  
STUDY POPULATION: 
   The study population included diabetic patients without retinopathy, with retinopathy, 
non diabetic healthy controls who came to diabetology outpatient department after fasting 
and post prandial blood investigation. Fundoscopy was performed by expert 
ophthalmologist .Patients with retinopathy and no retinopathy was categorized based on 
International disease severity scale for DR by Wilkinson which proposes five levels for 
grading of DR, based on risk of progression Classification is worded as follows: none, 
mild non proliferative diabetic retinopathy, moderate non proliferative diabetic 
retinopathy, severe non proliferative diabetic retinopathy or proliferative diabetic 
retinopathy. Normal healthy controls were also taken from general medicine Out Patient 
Department who comes for diabetic screening purpose. Systolic and diastolic blood 
pressure measurements were done. 
The final population enrolled in this study composed of 55 patients with non proliferative 
diabetic retinopathy, 68 diabetic patients without retinopathy, 90 healthy controls without 
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diabetic retinopathy. All patients were required to provide written informed consent 
before study participation. 
COLOUR DOPPLER IMAGING: Patients to be in supine position and sterile gel will be 
placed in closed eyelid. Measurements include Peak Systolic Velocity (PSV), End Diastolic 
Velocity (EDV) in ophthalmic arteries, central retinal artery and central retinal vein. 
Resistive Index (RI) and Pulsatile Index (PI) will be measured by the following formula. 
 Resistive Index (RI) = PSV-EDV/PSV; Pulsatile Index (PI) = PSV-EDV/V mean;  
V mean=1/3(PSV-EDV) + EDV. 
The eye with severe retinopathy is selected and if retinopathy is equal in both eyes, the 
right eye is selected for further evaluation. The signal localized from ophthalmic artery in 
upper part of intraocular region to optic nerve. The RI of OA was measured near the 
nasal side of the optic nerve where it crosses OA, behind the 3–5 cm of globe. CRA was 
visualized on the localization of the optic nerve head and measurements were taken 5–10 
mm behind the optic disc. The ocular vessels identified and flow characteristics i.e., the 
arterial flow is pulsatile and is usually red (toward the probe) whereas venous flow has 
continuous spectrum and is blue (away from the probe). CRA waveform shows pulsatile 
arterial flow with a steep systolic peak suggesting a high-resistance distal vascular bed. 
The CRV shows a much more continuous waveform but with a small degree of 
pulsatility. No age specific nomograms were available for PSV and EDV values were 
available. So wide age range of at risk population was considered. Orbital Doppler 
indices were compared in each group. 
 Representative cases 
Technique: 
  
  
 
 
 
  
 Orbital vessels pulse wave pattern: 
 
 
 
 CASE:1 
 
Opthalmic Artery in a normal healthy control showing systolic peak, dicrotic incisura, 
slightly diastolic flow declination noted. 
PSV: 32.5cm/s 
EDV: 10.5 cm/s 
PI: 1.106 
RI: 0.677 
 
  
Central retinal Artery in a normal healthy control shows the rounded systolic peak and 
the continuous flow during diastole in the arterial waveform. 
PSV: 11.3cm/s 
EDV: 4.2 cm/s 
PI: 1.024 
RI: 0.632 
 
  
Central retinal vein in a normal healthy control  
PSV: 8.7cm/s 
EDV: 4.1 cm/s 
PI: 0.875 
RI: 0.534 
 
 
 Case:2 
 
Opthalmic Artery in a normal healthy control  
PSV: 36.8 cm/sec 
EDV: 4.5 cm/sec 
PI: 0.607 
EDV: 14.5 
 
  
 
Central retinal artery in a normal healthy control 
PSV: 10.9cm/s 
EDV: 5.4cm/s 
PI: 0.614 
RI: 0.504 
 
  
Central retinal vein in a normal healthy control .Minimal pulsatility noted in  the central 
retinal vein. 
PSV: 9.3cm/s 
EDV: 4.3 cm/s 
PI: 0.768 
RI: 0.533 
 
 
 CASE:3 
 
 Opthalmic artery in a diabetic without retinopathy 
   PSV: 36.4 cm/s 
   EDV: 10.8 cm/s 
   PI: 1.273 
   RI: 0.704 
 
  
Central retinal artery in a diabetic without retinopathy  
PSV: 15.4 cm/sec 
EDV: 3.9 cm/sec 
PI: 1.401 
RI:0.747 
                                        
 
 
 
  
Central retinal vein in a diabetic without retinopathy The venous flow is low and 
continuous, with a peak in flow velocity (arrowhead) a fixed time after the systolic peak. 
 
PSV: 8 cm/sec 
EDV: 5 cm/sec 
PI: 0.465 
RI: 0.372 
 
  
 Case:4 
 
Opthalmic artery in a diabetic patient without retinopathy 
PSV: 31.9.9 cm/sec 
EDV: 8.7cm/sec 
PI: 1.487 
RI: 0.727 
 
 
 
  
Central retinal artery in a diabetic patient without retinopathy 
PSV: 11.3 cm/sec 
EDV: 2.7 cm/sec 
PI: 1.349 
RI: 0.766 
 
 
 
 
 
  
 
 
Central retinal vein in a diabetic patient without retinopathy 
PSV: 6.2cm/sec 
EDV: 1.8 cm/sec 
PI: 1.207 
RI: 0.714 
 
 
 
                                         
CASE:5 
 
                                    Opthalmic artery in a patient with diabetic retinopathy 
PSV: 30.5 cm/sec 
EDV: 4.9 cm/sec 
PI: 2.428 
RI: 0.838 
EDV was found to be lower with increased PI and RI in diabetic retinopathy group. 
No statistical significance was found with PSV 
   
 
 
 
Central retinal artery in a diabetic patient with retinopathy 
PSV :13.4 cm/sec 
EDV :3.4 cm/sec 
PI :1.424 
RI :0.750 
EDV was found to be lower with increased PI and RI in diabetic retinopathy group. 
No statistical significance was found with PSV 
  
                                   
 
 
 
Central retinal vein in a diabetic patient with retinopathy 
PSV: 6.9 cm/sec 
EDV: 3.4 cm/sec 
PI: 0.812 
RI: 0.514 
PSV was found to be higher with increased PI and RI in diabetic retinopathy group  
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6.  STATISTICAL METHODS 
Orbital Doppler parameters were considered as primary outcome variable. Study group 
(Diabetic retinopathy Vs Diabetic without retinopathy Vs Non diabetic) were considered 
as Primary explanatory variable.  
Descriptive analysis was carried out by frequency and proportion for categorical 
variables. Data was also represented using appropriate diagrams like bar diagram, pie 
diagram and scatter diagram. 
All the age, weight, height, systolic blood pressure, diastolic blood pressure, fasting 
blood sugar, post prandial blood sugar, HbA1c, ophthalmic artery parameter, central 
retinal artery and central retinal vein (PSV, EDV, PI, RI) were checked for normal 
distribution within each category of diabetic retinopathy, diabetic no retinopathy and non-
diabetic by using visual inspection of histograms and normality Q-Q plots. Shapiro- wilk 
test was also conducted to assess normal distribution.  Shapiro wilk test p value of >0.05 
was considered as normal distribution. 
. For non-normally distributed age, weight, height, systolic blood pressure, diastolic 
blood pressure, fasting blood sugar, post prandial blood sugar, HbA1c, ophthalmic artery 
parameter, central retinal artery and central retinal vein (PSV, EDV, PI,RI), Medians and 
Interquartile range (IQR) were compared across study groups(diabetic retinopathy, 
diabetic without retinopathy and non-diabetic )using Kruskal Wallis test  
Categorical gender was compared across study groups (diabetic retinopathy, diabetic 
without retinopathy and non-diabetic) using Chi square test  
Association between ophthalmic artery parameter, central retinal artery and central retinal 
vein (PSV, EDV, PI, RI) and HbA1c variables was assessed by calculating spearman 
rank correlation coefficient and the data was represented in a scatter diagram. 
P value < 0.05 was considered statistically significant. IBM SPSS version 22 was used 
for statistical analysis.  
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                                             7.  OBSERVATION AND RESULTS: 
A total of 213 subjects were included in the analysis. 
Table 7.1: Descriptive analysis of group in the study population (N=213)  
 
Study group Frequency Percentages 
Diabetic retinopathy 55 25.80% 
Diabetic without  
retinopathy 
68 31.90% 
Non diabetic 90 42.30% 
 
A total of 55 diabetic retinopathy,68 diabetics without retinopathy and 90 non diabetic 
were included in the final analysis (Table: 7.1 & figure 7.1) 
Figure 7. 1: Pie chart of study group in the study population (N=213) 
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Table 7. 2: Comparison of median values in age across the study group (N=213)  
Parameter 
Study group  
Median (IQR) 
Kruskal 
Wallis 
test 
(P value) 
Diabetic with 
retinopathy 
Diabetic  
Without 
retinopathy 
Non diabetic 
Age (in years) 
53 
(48 to 60) 
52 
 (40.50 to 60 ) 
50 
(45 to 56) 
0.139 
 
Among the people with diabetic retinopathy median age was 53 years (IQR 48 to 60),  
the median age of 52 years (IQR 40.50 to 60) among  diabetic without retinopathy group, 
and 50 years (IQR 45 to 56) among non-diabetic. The difference in the median age across 
study group was statistically not significant (P value 0.139). 
 
Figure 7.2: Bar chart of comparison of median age across the study group (N=213) 
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Table7. 3: Comparison of study group with gender (N=213)  
 
Gender 
Study group 
Chi 
square 
  
P-value 
  
Diabetic 
retinopathy 
(N=55) 
Diabetic without 
retinopathy 
(N=68) 
Non diabetic 
(N=90) 
Male 34 (61.8%) 39 (57.4%) 45 (50%) 
2.084 0.353 
Female 21 (38.2%) 29 (42.6%) 45 (50%) 
Among the people with diabetic retinopathy, 34(61.8%) participants were males and 
21(38.2%) participants were females. Among the diabetic non-retinopathy group, 39 
(57.4%) participants were males and 29 (42.6%) participants were females. Among non-
diabetic population, 45 (50%) participants were males and 45 (50%) participants were 
females, the difference in the proportion of gender across study group was statistically 
not significant (p value 0.353). 
Figure 7.3: Cluster bar chart of comparison of study group with gender (N=213) 
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Table7.4: Comparison of anthropometric parameters across the study group 
(N=213)  
Anthropometric 
parameter 
Diabetic retinopathy 
Median (IQR) 
Diabetic without 
retinopathy 
Median (IQR) 
Non diabetic 
Median (IQR) 
Kruskal 
Wallis 
test 
(P value) 
Height (in cm) 164 (161 to 168) 163(160 to 168) 
163(158.75 to 
165) 
0.036 
Weight (in kg) 62(58 to 66) 61.50(56 to 68) 60(54.75 to 64) 0.184 
 
Among the people with study group, diabetic retinopathy median height was 164 cm 
(IQR 161 to 168), it was 163 cm (IQR 160 to 168) among diabetic without retinopathy 
group, and 163 cm (IQR 158.75 to 165) among non-diabetic group. The difference in the 
median height across study group was statistically significant (P value 0.036). Among 
diabetic retinopathy group median weight was 62 kg (IQR 58 to 66), it was 61.50 kg 
(IQR 56 to 68) among  diabetic without retinopathy, and 60 kg (IQR 54.75 to 64) among  
non-diabetic population. The difference in the median weight across study group was 
statistically not significant (P value 0.184). 
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Figure 7.4: Bar chart of comparison of median height across the study group 
(N=213)
 
Figure 7. 5: Bar chart of comparison of median weight across the study group 
(N=213)
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Table 7.5: Comparison of median values in blood pressure across the study group 
(N=213)  
Blood pressure 
Diabetic retinopathy 
Median (IQR) 
Diabetic without 
retinopathy 
Median (IQR) 
Non diabetic 
Median (IQR) 
Kruskal 
Wallis 
test 
(P value) 
Systolic blood 
pressure 
118 (110 to 120) 118(110 to 120) 110(110 to 120) 0.009 
Diastolic blood 
pressure 
80(70 to 80) 80(70 to 80) 72(70 to 72) 0.102 
 
Among, diabetic retinopathy group, median Systolic blood pressure was 118 mm Hg 
(IQR 110 to 120), it was 118 mm Hg (IQR 110 to 120) among diabetic without 
retinopathy, and 110mm hg (IQR 110 to 120) among non-diabetic group. The difference 
in the median systolic blood pressure across study group was statistically significant (P 
value 0.009).  
Among the people with diabetic retinopathy median diastolic blood pressure was 
80mmhg (IQR 70 to 80) , It was 80  mm Hg (IQR 70 to 80) among diabetic without 
retinopathy, and 72 mm Hg (IQR 70 to 72) among  non-diabetic. The difference in the 
median diastolic blood pressure across study group was statistically not significant (P 
value 0.102). 
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Figure 7. 6: Bar chart of comparison of median systolic blood pressure across the 
study group (N=213)  
 
 
Figure 7.7: Bar chart of comparison of median diastolic blood pressure across the 
study group (N=213)  
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Table 7.6: Comparison of median values in blood test across the study group 
(N=213)  
Blood test 
Diabetic retinopathy 
Median (IQR) 
Diabetic without 
retinopathy 
Median (IQR) 
Non diabetic 
Median (IQR) 
Kruskal 
Wallis 
test 
(P value) 
Fasting blood 
sugar 
260(199 to 311) 
232 (193.50 to 
282.25) 
91(84 to 99.50 <0.001 
Post prandial 
sugar 
308(256 to 380) 
282.50(246 to 
342) 
123(113 to 128) <0.001 
 
Among the people with diabetic retinopathy median fasting blood sugar was 260 gm/dl 
(IQR 119 to 311), it was 232 gm/dl (IQR 193.50 to 282.25) among diabetic without 
retinopathy group, and 91gm/dl (IQR 84 to 99.50) among non-diabetic. The difference in 
the median fasting blood sugar across study group was statistically significant (P value 
<0.001). Among the people with diabetic retinopathy median post prandial sugar was 308 
gm/dl (IQR 256 to 380), it was 282.50 gm/dl (IQR 256 to 380) among diabetic without 
retinopathy, and 123  (IQR 113 to 128) among  non-diabetic. The difference in the 
median post prandial sugar across study group was statistically significant (P value 
<0.001). 
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Figure 7.8: Bar chart of comparison of median fasting blood sugar across the study 
group(N=213) 
 
Figure7. 9: Bar chart of comparison of median post prandial blood sugar across the 
study group (N=213)  
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Table7.7: Comparison of median values in HbA1c across the study group (N=213) 
Parameter 
Diabetic retinopathy 
Median (IQR) 
Diabetic without 
retinopathy 
Median (IQR) 
Non diabetic 
Median (IQR) 
Kruskal 
Wallis 
test 
(P 
value) 
HbA1c 8.20(7.80 to 9) 7.40 (7.10 to 7.60) 4.90(4.50 to 5.10) <0.001 
Among the people with study group, diabetic retinopathy median HbA1c was 8.20(IQR 
7.80 to 9), it was 7.40 (IQR 7.10 to 7.60) among diabetic without retinopathy group and 
4.90  (IQR 4.50 to 5.10) among non-diabetic. The difference in the median HbA1c across 
study group was statistically significant (P value <0.001). 
Figure 7.10: Bar chart of comparison of median HbA1c across the study group 
(N=213) 
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Table 7.8: Comparison of ophthalmic artery parameters across the study group 
(N=213)  
Ophthalmic 
artery  
Diabetic retinopathy 
Median (IQR) 
Diabetic without 
retinopathy 
Median (IQR) 
Non diabetic 
Median (IQR) 
Kruskal 
Wallis 
test 
(P value) 
PSV 32.90 (27.80 to 40.50) 
31.25 (25.92 to 
34.57) 
30.90(29.67 
to32.52) 
0.347 
EDV 5.20(4.10 to 7.40) 6.85(5.12 to8.47) 7.50(7.05 to 8.90) <0.001 
PI 2.04(1.73 to 2.30) 
1.65 (1.45 to 
1.87) 
1.52 (1.36 to 
1.55) 
<0.001 
RI 0.83 (0.79 to 0.87) 0.77(0.73 to 0.80) 
0.75 (0.72 to 
0.76) 
<0.001 
 
Among, diabetic retinopathy group, median PSV of ophthalmic artery was 32.90 (IQR 
27.80 to 40.50) , it was  31.25 (IQR 25.92 to 34.57) among diabetic without retinopathy 
group, and 30.90 (IQR 29.67 to 32.52) among  non-diabetic. The difference in the median 
PSV across study group was statistically not significant (P value 0.347).  
Among, diabetic retinopathy group, median EDV of ophthalmic artery was 5.20 (IQR 
4.10 to 7.40), it was 6.85 (IQR 5.12 to 8.47) among diabetic without retinopathy, and 
7.50 (IQR 7.05 to 8.90) among non-diabetic. The difference in the median EDV across 
study group was statistically significant (P value <0.001).  
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Among, diabetic retinopathy group, median PI of ophthalmic artery was 2.04 (IQR 1.73 
to 2.30), it was 1.65 (IQR 1.45 to 1.87) among diabetic non-retinopathy, and 1.52 (IQR 
1.36 to 1.55) among non-diabetic. The difference in the median PI across study groups 
was statistically significant (P value <0.001).  
Among, diabetic retinopathy group, median RI of ophthalmic artery was 0.83 (IQR 0.79 
to 0.87), it was 0.77 (IQR 0.73 to 0.80) among diabetic without retinopathy, and 0.75 
(IQR 0.72 to 0.76) among non-diabetic. The difference in the median RI across study 
groups was statistically significant (P value <0.001) 
Figure 7.11: Bar chart of comparison of median OA PSV across the study group 
(N=213) 
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Figure7. 12: Bar chart of comparison of median OA EDV across the study group 
(N=213) 
 
 
Figure7. 13: Bar chart of comparison of median OA PI across the study group 
(N=213) 
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Figure 7.14: Bar chart of comparison of median OA RI across the study group 
(N=213) 
 
 
Table7.9: Comparison of central retinal artery parameters across the study group 
(N=213)  
Central retinal 
artery  
Diabetic retinopathy 
Median (IQR) 
Diabetic  without 
retinopathy 
Median (IQR) 
Non diabetic 
Median (IQR) 
Kruskal 
Wallis 
test 
(P value) 
PSV 11.70 (7.97 to 15.45) 
10.15 (8.57 to 
14.05) 
11(10.10 to 
11.85) 
0.343 
EDV 2.20(1.80 to 3.23) 2.60 (2 to 3.63) 
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<0.001 
PI 1.48(1.33 to 1.74) 
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1.74) 
1.35 (1.22 to 
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RI 0.77 (0.73 to 0.84) 0.76(0.71 to 0.82) 
0.67 (0.63 to 
0.73) 
<0.001 
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Among, diabetic retinopathy group, median PSV of Central Retinal artery was 11.70 
(IQR 7.97 to 15.45), it was 10.15 (IQR 8.57 to 14.05) among diabetic without retinopathy 
group and 11 (IQR 10.10 to 11.85) among non-diabetic. The difference in the median 
PSV of Central Retinal artery across study groups was statistically not significant (P 
value 0.343).  
Among, diabetic retinopathy group, median EDV of Central Retinal artery was 2.20 
(IQR 1.80 to 3.23), it was 10.15 (IQR 8.57 to 14.05) among diabetic without retinopathy, 
and 11 (IQR 10.10 to 11.85) among non-diabetic population. The difference in the 
median EDV of Central Retinal artery across study groups was statistically significant 
(P value <0.001).  
Among, diabetic retinopathy group, median PI of Central Retinal artery was 1.48 (IQR 
1.33 to 1.74), it was 1.46 (IQR 1.30 to 1.74) among diabetic without retinopathy, and 
1.35 (IQR 1.22 to 1.55) among non-diabetic. The difference in the median PI  of Central 
Retinal artery across study groups was statistically significant (P value <0.001).  
Among, diabetic retinopathy group, median RI of Central Retinal artery was 0.77 (IQR 
0.79 to 0.84), it was 0.76 (IQR 0.71 to 0.82) among diabetic without retinopathy, and 
0.67 (IQR 0.63 to 0.73) among non-diabetic. The difference in the median RI of Central 
Retinal artery across study groups was statistically significant (P value <0.001) 
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Figure 7.15: Bar chart of comparison of median CRA PSV across the study group 
(N=213) 
 
 
 
Figure7. 16: Bar chart of comparison of median CRA EDV across the study group 
(N=213) 
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Figure7. 17: Bar chart of comparison of median CRA PI across the study group 
(N=213) 
 
 
Figure 7.18: Bar chart of comparison of median CRA RI across the study group 
(N=213) 
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Table7. 10: Comparison of median values in central retinal vein across the study 
group (N=213)  
 
Central retinal 
vein 
Diabetic retinopathy 
Median (IQR) 
Diabetic without 
retinopathy 
Median (IQR) 
Non diabetic 
Median (IQR) 
Kruskal 
Wallis 
test 
(P value) 
PSV 8 (6 to 10.10) 
7.60 (5.60 to 
9.22) 
5.50(5 to 8.52) <0.001 
EDV 3.90 (2.90 to 5.20) 3.90 (3 to 4.77) 
3.55 (3.17 to 
4.32) 
0.727 
PI 0.74 (0.49 to 0.98) 
0.60 (0.43 to 
0.88) 
0.47 (0.38 to 
0.75) 
0.001 
RI 0.50 (0.39 to 0.60) 0.46(0.35 to 0.58) 
0.37 (0.30 to 
0.54) 
0.002 
 
Among the, diabetic retinopathy group median PSV of central retinal vein was 8 (IQR 6 
to 10.10),  it was 7.60 (IQR 5.60 to 9.22) among  diabetic without retinopathy, and 5.50 
(IQR 5 to 8.52) among non-diabetic. The difference in the median PSV of central retinal 
vein across study group was statistically significant (P value <0.001).  
Among the, diabetic retinopathy group median EDV of central retinal vein was 3.90 
(IQR 2.90 to 5.20), it was 3.90 (IQR 3 to 4.77) among diabetic without retinopathy, and 
3.55 (IQR 3.17 to 4.32) among non-diabetic. The difference in the median EDV of 
central retinal vein across study group was statistically not significant (P value 0.727).  
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Among the, diabetic retinopathy group median PI of central retinal vein was 0.74 (IQR 
0.49 to 0.98), it was 0.60 (IQR 0.43 to 0.88) among diabetic without retinopathy, and 
0.47 (IQR 0.38 to 0.75) among non-diabetic. The difference in the median PI of central 
retinal vein across study group was statistically significant (P value 0.001)  
Among the, diabetic retinopathy group median RI of central retinal vein was 0.50 (IQR 
0.39 to 0.60), it was 0.46 (IQR 0.35 to 0.58) among diabetic without retinopathy, and 
0.37 (IQR 0.30 to 0.5) among non-diabetic. The difference in the median RI of central 
retinal vein across study group was statistically significant (P value 0.002) 
 
Figure 7.19: Bar chart of comparison of median CRV PSV across the study group (N=213) 
 
 
 
 
  
8 
7.6 
5.5 
0
1
2
3
4
5
6
7
8
9
Diabetic retinopathy Diabetic no retinopathy Non diabetic
P
S
V
(M
ed
ia
n
) 
Study group 
 67 
Figure7. 20: Bar chart of comparison of median CRV EDV across the study group (N=213) 
 
 
 
 
 
 
Figure 7.21: Bar chart of comparison of median CRV PI across the study group (N=213) 
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Figure 7.22: Bar chart of comparison of median CRV RI across the study group (N=213) 
 
 
 
 
 
 
Table7. 11: Comparison of study group with fundos copy (N=213)  
 
Fundos copy 
Study group 
Diabetic retinopathy 
(N=55) 
Diabetic without 
retinopathy 
(N=68) 
Non diabetic 
(N=90) 
Normal 0 (0%) 68 (100%) 90 (100%) 
Mild 39 (70.9%) 0 (0%) 0 (0%) 
Moderate 14(25.5%) 0 (0%) 0 (0%) 
Severe 2(3.6%) 0 (0%) 0 (0%) 
*No statistical test was applied -due to 0 subjects in the cells 
 
Among the people with diabetic retinopathy, 39 (70.9%) participants had mild 14 (25.5%) 
participants had moderate and 2(3.6%) participants had severe. Among the people with diabetic 
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without retinopathy, 68 (100%) participants had normal. Among the people with non -diabetic, 
90 (100%) participants had normal. 
 
Figure7. 23: Cluster bar chart of comparison of study group with fundoscopy (N=213) 
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DOPPLER PARAMETER OF OPHTHALMIC ARTERY: 
 
Table 7.12: correlation between HbA1c and ophthalmic artery PSV among diabetic 
population (N=123)  
 
Parameter 
 
Spearman rank Correlation 
(rs) 
 
P value 
 
PSV 
 
0.048 
 
0.601 
 
There was a weak positive correlation between HbA1c and PSV (rs value: 0.048, P value 0.601) 
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Table7. 13: correlation between HbA1c and ophthalmic artery EDV among diabetic 
population (N=123)  
 
Parameter  
Spearman rank Correlation 
(rs) 
P value 
EDV -0.132 0.145 
 
 
There was a weak negative correlation between HbA1c and EDV (rs value: -0.132, P value 
0.145) 
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Table7. 14: correlation between HbA1c and ophthalmic artery PI among diabetic 
population (N=123)  
 
Parameter  
Spearman rank Correlation 
(rs) 
P value 
PI 0.204 0.024 
 
 
 
 
There was a weak positive correlation between HbA1c and PI (rs value: 0.204, P value 0.024) 
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Table 7.15: correlation between HbA1c and ophthalmic artery RI among diabetic 
population (N=123)  
 
Parameter  
Spearman rank Correlation 
(rs) 
P value 
RI 0.147 0.106 
 
 
 
There was a weak positive correlation between HbA1c and RI (rs value: 0.147, P value 0.106) 
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DOPPLER PARAMETER OF CENTRAL RETINAL ARTERY: 
Table7. 16: correlation between HbA1c and central retinal artery PSV among diabetic 
population(N=123)  
 
Parameter  Spearman rank Correlation 
(rs) 
P value 
PSV -0.025 0.781 
 
 
 
There was a weak negative correlation between HbA1c and PSV (rs value: -0.025, P value 0.781) 
 75 
Table 7.17: correlation between HbA1c and central artery EDV among diabetic 
population(N=123)  
 
Parameter  Spearman rank Correlation 
(rs) 
P value 
EDV -0.115 0.208 
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There was a weak negative correlation between HbA1c and EDV (rs value: -0.115, P value 
0.208) 
 
Table 7.18: correlation between HbA1c and central artery PI among diabetic population 
(N=123)  
 
 parameter  Spearman rank Correlation 
(rs) 
P value 
PI 0.055 0.547 
 
 
There was a weak positive correlation between HbA1c and PI (rs value: 0.055, P value 0.547) 
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Table7. 19: correlation between HbA1c and Doppler parameters of central artery RI 
among diabetic population (N=123)  
 
 
 
 Parameter  
 
Spearman rank Correlation 
(rs) 
 
P value 
RI 0.107 0.238 
 
 
 
There was a weak positive correlation between HbA1c and RI (rs value: 0.107, P value 0.238) 
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DOPPLER PARAMETER OF CENTRAL RETINAL VEIN:  
 
Table 7.20: correlation between HbA1c and Doppler parameters of central retinal vein 
PSV among diabetic population (N=123)  
 
Doppler parameter of 
Central retinal vein 
Spearman rank Correlation 
(rs) 
P value 
PSV 0.069 0.449 
 
There was a weak positive correlation between HbA1c and PSV (rs value: 0.069, P value 0.449) 
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Table 7.21: correlation between HbA1c and Doppler parameters of central retinal vein 
EDV among diabetic population (N=123)  
 
Doppler parameter of 
Central retinal vein 
Spearman rank Correlation 
(rs) 
P value 
EDV 0.034 0.711 
 
 
 
There was a weak positive correlation between HbA1c and EDV (rs value: 0.0.034, P value 
0.711) 
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Table 7.22: correlation between HbA1c and doppler parameters of central retinal vein   PI 
among diabetic population(N=123)  
 
Doppler parameter of 
Central retinal vein 
Spearman rank Correlation 
(rs) 
P value 
PI 0.060 0.512 
 
 
 
There was a weak positive correlation between HbA1c and PI (rs value: 0.060, P value 0.512) 
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Table 7.23: Correlation between HbA1c and doppler parameters of central retinal vein RI 
among diabetic population(N=123)  
Parameter  Spearman rank Correlation 
(rs) 
P value 
RI 0.007 0.939 
 
 
 
 
There was a weak positive correlation between HbA1c and RI (rs value: 0.007, P value 0.939) 
 
  
 82 
8. DISCUSSION 
Diabetes mellitus has emerged as major public health problem in recent times, globally 
and in India. As per International diabetes federation estimates, in 2017 there are 451 
million (age 18-99  years) diabetic population globally, which is projected to increase to 
693 million by 2045
[63]
. As per recently published ICMR-INDIAB study, the overall 
prevalence of diabetes in India was 7·3% (95% CI 7·0-7·5) affecting the entire spectrum 
of community. This will translate into huge absolute number of patients with diabetes in 
India, contributing to significant chunk of diabetes population of the world
 [64]
.
 
Diabetes 
and associated metabolic derangement has adverse impact on various end organs.  Intra 
ocular tissue, especially retinal vasculature is one of the important end organ. Diabetic 
retinopathy, usually reported to occur after 5 to 10 years of onset of the disease is a form 
of microangiopathy is the most common ocular manifestations of diabetes mellitus.
[65]
. 
Some previous studies suggested that most patients with diabetes develop characteristic 
abnormalities of retinal blood vessels, which include retinal capillary bed obstructions, 
capillary dropout, progressive thickening of the basement membrane, micro- aneurysms, 
venous abnormalities, arterio-venous shunts, subsequent neovasculature development, 
and blood rheologic abnormalities in the orbital vessels, including increased blood and 
plasma viscosities, increased red blood cell aggregation, increased platelet aggregation, 
and platelet shape changes. These abnormalities seem to disturb the retinal 
microcirculation and reduce the retinal blood flow if not compensated by regulatory 
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mechanisms. Based on the above findings, great importance should be attached to 
analysis of the ocular circulation in patients with diabetes
[66-68]
. 
The examinations used in assessing diabetic retinopathy usually involve imaging 
of the vessels in the eyeball and the retina. These include, fluorescein angiography, 
optical coherence tomography of the retina, B-mode ultrasound imaging, perimetry and 
digital retinal photography. There are many papers that discuss the correlations between 
retrobulbar circulation alterations and progression of diabetic retinopathy based on 
Doppler sonography. Color Doppler imaging is a non-invasive method enabling 
measurements of blood flow velocities in small vessels of the eyeball. The most 
frequently assessed vessels include: the ophthalmic artery, which is the first branch of the 
internal carotid artery, as well as the central retinal vein and artery, and the posterior 
ciliary arteries. The analysis of hemodynamic alterations in the retrobulbar vessels may 
deliver important information concerning circulation in diabetes and help to answer the 
question whether there is a relation between the progression of diabetic retinopathy and 
the changes observed in blood flow in the vessels of the eyeball. This paper presents the 
overview of literature regarding studies on blood flow in the vessels of the eyeball in 
patients with diabetic retinopathy
.[3]
. 
Color Doppler imaging has been used in ophthalmology as a safe, non-invasive 
method for evaluating hemodynamic alterations in the orbital vessels for 20 years.
[26]
This 
sonographic technique combines a simultaneous B-mode sonogram with colors 
representing movements based on Doppler frequency shifts and allows assessment of 
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blood flow velocities, including peak systolic velocity (PSV) and end-diastolic velocity 
(EDV), in retrobulbar vessels. In addition, the resistive index (RI), a measure of 
peripheral vascular resistance, is calculated for each retro- bulbar vessel at the same time. 
[40]
Numerous studies have reported reduced PSV, EDV, and RI in the retro bulbar 
vessels, whereas others have reported increased PSV, EDV, and RI in these vessels, 
including the ophthalmic artery, central retinal artery, and short posterior ciliary artery, of 
diabetic patients without or with retinopathy.  
Considering scarcity of studies comparing the retro orbital blood flow parameters 
using doppler among diabetic people with and without retinopathy, the current study was 
conducted in a tertiary care teaching hospital in south India. Among 55 people with 
diabetic retinopathy, 39 (70.9%) participants had mild 14 (25.5%) participants had 
moderate and 2(3.6%) participants had severe DR. The study also included a group of 
healthy controls to further understand association between diabetes and ocular blood flow 
parameters. The average age of all the three study groups was about 50 years, with no 
statistically significant difference across the study groups. In both the diabetes groups 
(with and without retinopathy) the proportion of males was slightly higher, as compared 
to equal number of males and females among control group. But the gender composition 
across the study groups, showed no statistically significant difference. The other key 
confounding variable compared across the 3 groups was systolic and diastolic blood 
pressure, which also hadn’t shown any significant difference between diabetic population 
with and without retinopathy (118 mm of hg), but was slightly lesser among control 
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group (110 mm of Hg). The diastolic BP was 80 mm of hg in both diabetes groups, but 
was 72 mm of Hg among healthy group. The fasting, post prandial blood sugar values 
and HbA1c had shown very poor glycemic control among diabetic people with 
retinopathy, as compared to diabetic population without retinopathy. Among control 
group, the blood glucose parameters were within normal physiological range.  
It is very important to consider the differences in the demographic, diabetes 
related parameters and co-morbidities between the study population groups, while 
comparing the current study findings with other studies. In a by Sood, S., et al
[69]
who 
have studied ocular blood flow parameters before and after treatment among a group of 
diabetics with retinopathy, before and after treatment, the age range  of patients was 
between 38 to 75 years (mean age 55.8 ± 8.4 years). The proportion of males was 56%. 
These findings were comparable with diabetic population in the current study. In contrast 
to current study, the proportion of mild non-proliferative diabetic retinopathy (NPDR) 
was only 54% and higher proportion (46%) had moderate NPDR and none had severe 
NPDR.  
COMPARISON OF OPHTHALMIC ARTERY PARAMETERS:  
Among, diabetic retinopathy group, median PSV of ophthalmic artery was 32.90 
(IQR 27.80 to 40.50), it was 31.25(IQR 25.92 to 34.57) among diabetic non retinopathy 
group, and 30.90 (IQR 29.67 to 32.52) among non-diabetic. The difference in the median 
PSV across study group was statistically not significant (P value 0.347). Among, diabetic 
retinopathy group, median EDV of ophthalmic artery was 5.20 (IQR 4.10 to 7.40), it was 
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6.85(IQR 5.12 to 8.47) among diabetic non retinopathy, and 7.50 (IQR 7.05 to 8.90) 
among non-diabetic. The difference in the median EDV across study group was 
statistically significant (P value <0.001).  
Among, diabetic retinopathy group, median PI of ophthalmic artery was 2.04 (IQR 
1.73 to 2.30), it was 1.65(IQR 1.45 to 1.87) among diabetic non-retinopathy, and 1.52 
(IQR 1.36 to 1.55) among non-diabetic. The difference in the median PI across study 
groups was statistically significant (P value <0.001). Among, diabetic retinopathy group, 
median RI of ophthalmic artery was 0.83 (IQR 0.79 to 0.87), it was 0.77(IQR 0.73 to 
0.80) among diabetic non-retinopathy, and 0.75 (IQR 0.72 to 0.76) among non-diabetic. 
The difference in the median RI across study groups was statistically significant (P value 
<0.001).  
As per study by Sood, S., et al
.[69]
 the PSV, EDV and RI of Ophthalmic Artery 
among  people affected by diabetic retinopathy were 33.42 ± 18.02,7 9.12 ± 4.93 and 
0.75 ± 0.07 respectively. This study had not compared the Doppler parameters with non-
diabetic retinopathy/ control groups as in our study. But the Doppler parameters in 
diabetic people with retinopathy were closer to current study findings.  
Basturk, T., et al
.[70]
 have evaluated only resistive Index (RI) values of orbital 
arteries by using the color Doppler imaging (CDI) in type II diabetes mellitus (DM) 
patients with microalbuminuria. In this study, the DM patients with microalbuminuria 
were grouped into two: group 1 consisted of patients with retinopathy (n = 51) and group 
2 consisted of patients without retinopathy (n = 40). Healthy subjects constituted group 3 
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(n = 27). Compared to diabetic group 2, group 1 had significantly higher mean RIs of 
OA, CRA, PCA, and HbA1c levels (p < 0.001 for all). Besides, there were no statistical 
differences in mean RIs of OA, CRA, and PCA between the control group and group 2 (p 
= 1.0; p = 0.44; p = 0.67, respectively). Mean RIs of OA and PCA were significantly 
correlated with age in group 1 (r = 0.549, p < 0.001; r = 0.407, p = 0.003, respectively). 
Mean RI of CRA was significantly correlated with the duration of diabetes and age in 
group 1 (r = 0.296, p = 0.035; r = 0.486, p < 0.001, respectively). The authors have 
concluded that, RI might be a useful marker for early diagnosis and follow-up of diabetic 
retinopathy, and orbital RI assessment would be beneficial for diabetic patients with 
retinopathy. 
   Similar to our study, Karami, M., et al.
[71] 
compared orbital blood flow velocities 
using Doppler and gray-scale sonography in patients with DR, and to compare the results 
with those of their non-diabetic and diabetic peers without retinopathy. Similar to our 
study, compared with healthy controls, the age-adjusted resistive Index of the ophthalmic 
artery were significantly higher in patients with DR (p < 0.05). After further adjustment 
for age, gender, HbA1c, fasting plasma glucose, blood pressure, BMI, cholesterol, HDL, 
LDL, and triglycerides, only the resistivity index of the ophthalmic artery and the central 
retinal vein remained significantly higher in patients with DR compared with healthy 
controls.  
    Similar to our study, Krasnicki, P., et al.
[57] 
have studied 3 groups: group I--
control group, group II--type 2 diabetes patients without diabetic retinopathy, group III--
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type 2 diabetes patients with non proliferative diabetic retinopathy. Peak systolic blood 
velocity (PSV) and end-diastolic blood velocity (ESV) in ophthalmic artery (OA) in 
diabetic patients were significantly lower in comparison to the control group. Peak 
systolic blood velocity (PSV) and end-diastolic blood velocity (ESV) in central retinal 
artery (CRA) were significantly lower only in patients with diabetic retinopathy. Diabetes 
duration was significantly longer in group III in comparison to group II. Based on the 
findings, the authors concluded that Blood flow in ophthalmic artery is decreased in 
patients with diabetes. Reduction of blood flow in central retinal artery and short 
posterior ciliary arteries can be significant in the development of diabetic retinopathy. 
COMPARISON OF CENTRAL RETINAL ARTERY PARAMETERS:  
Among, diabetic retinopathy group, median PSV of Central Retinal artery was 
11.70 (IQR 7.97 to 15.45), it was 10.15(IQR 8.57 to 14.05) among diabetic without 
retinopathy group and 11 (IQR 10.10 to 11.85) among non-diabetic. The difference in the 
median PSV of Central Retinal artery across study groups was statistically not significant 
(P value 0.343).Among, diabetic retinopathy group, median EDV of Central Retinal 
artery was 2.20 (IQR 1.80 to 3.23), it was 10.15(IQR 8.57 to 14.05) among diabetic non 
retinopathy, and 11 (IQR 10.10 to 11.85) among non-diabetic population. The difference 
in the median EDV of Central Retinal artery across study groups was statistically 
significant (P value <0.001).Among, diabetic retinopathy group, median PI of Central 
Retinal artery was 1.48 (IQR 1.33 to 1.74), it was 1.46(IQR 1.30 to 1.74) among diabetic 
non retinopathy, and 1.35 (IQR 1.22 to 1.55) among non-diabetic. The difference in the 
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median PI of Central Retinal artery across study groups was statistically significant (P 
value <0.001). Among, diabetic retinopathy group, median RI of Central Retinal artery 
was 0.77 (IQR 0.79 to 0.84), it was 0.76(IQR 0.71 to 0.82) among diabetic non-
retinopathy, and 0.67 (IQR 0.63 to 0.73) among non-diabetic. The difference in the 
median RI of Central Retinal artery across study groups was statistically significant (P 
value <0.001) 
As per study by Sood, S., et al.
[69] 
the PSV, EDV and RI of Central Retinal Artery among 
people affected by diabetic retinopathy were 14.28 ± 11.21,5.64 ± 3.81 and 0.67 ± 
0.10respectively. This study had not compared the doppler parameters with non-diabetic 
retinopathy/ control groups as in our study. But in the diabetic population with 
retinopathy PSV and RI values were almost similar to current study, but EDV values 
appeared to be considerably lower than the current study.  
Basturk, T., et al
[70]
have evaluated only resistive Index (RI) values of orbital arteries by 
using the color Doppler imaging (CDI) in type II diabetes mellitus (DM) patients with 
microalbuminuria. In this study, the DM patients with microalbuminuria were grouped 
into two: group 1 consisted of patients with retinopathy (n = 51) and group 2 consisted of 
patients without retinopathy (n = 40). Healthy subjects constituted group 3 (n = 27). 
Compared to diabetic group 2, group 1 had significantly higher mean RIs of OA, CRA, 
PCA, and HbA1c levels (p < 0.001 for all). Besides, there were no statistical differences 
in mean RIs of OA, CRA, and PCA between the control group and group 2 (p = 1.0; p = 
0.44; p = 0.67, respectively). Mean RIs of OA and PCA were significantly correlated 
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with age in group 1 (r = 0.549, p < 0.001; r = 0.407, p = 0.003, respectively). Mean RI of 
CRA was significantly correlated with the duration of diabetes and age in group 1 (r = 
0.296, p = 0.035; r = 0.486, p < 0.001, respectively). The authors have concluded that, RI 
might be a useful marker for early diagnosis and follow-up of diabetic retinopathy, and 
orbital RI assessment would be beneficial for diabetic patients with retinopathy. 
Similar to our study, Karami, M., et al.
[71]
 compared orbital blood flow velocities using 
Doppler and gray-scale sonography in patients with DR, and to compare the results with 
those of their non-diabetic and diabetic peers without retinopathy. Similar to our study, 
compared with healthy controls, the age-adjusted resistive Index of the ophthalmic artery 
were significantly higher in patients with DR (p < 0.05). After further adjustment for age, 
gender, HbA1c, fasting plasma glucose, blood pressure, BMI, cholesterol, HDL, LDL, 
and triglycerides, only the resistivity index of the ophthalmic artery and the central retinal 
vein remained significantly higher in patients with DR compared with healthy controls. 
Similar to our study, Krasnicki, P., et al.
[57]
 have studied 3 groups: group I--control group, 
group II--type 2 diabetes patients without diabetic retinopathy, group III--type 2 diabetes 
patients with non proliferative diabetic retinopathy. Peak systolic blood velocity (PSV) 
and end-diastolic blood velocity (ESV) in ophthalmic artery (OA) in diabetic patients 
were significantly lower in comparison to the control group. Peak systolic blood velocity 
(PSV) and end-diastolic blood velocity (ESV) in central retinal artery (CRA) were 
significantly lower only in patients with diabetic retinopathy. Diabetes duration was 
significantly longer in group III in comparison to group II. Based on the findings, the 
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authors concluded that Blood flow in ophthalmic artery is decreased in patients with 
diabetes. Reduction of blood flow in central retinal artery and short posterior ciliary 
arteries can be significant in the development of diabetic retinopathy. 
Neudorfer, M., et al.
[72]
have assessed long-term changes in the flow parameters of 
retrobulbar vessels among 4 groups of eyes. Eyes of diabetic patients without diabetic 
retinopathy (DR),eyes with non proliferative DR, eyes with proliferative DR, and eyes of 
non diabetic patients (controls). The resistive index (RI) values of the central retinal 
artery and posterior ciliary artery had increased in the two non-DR groups and in the non 
proliferative DR group, with a surprising decrease measured in eyes with proliferative 
DR. Combining the non proliferative DR and proliferative DR groups resulted in a milder 
increase of the RI of the posterior ciliary artery (P= NS) and the central retinal artery 
(P=0.02) in the DR group compared to the other groups.  
COMPARISON OF CENTRAL RETINAL VEIN PARAMETERS:  
Among the, diabetic retinopathy group median PSV of central retinal vein was 8 
(IQR 6 to 10.10),  it was 7.60(IQR 5.60 to 9.22) among diabetic without retinopathy, and 
5.50 (IQR 5 to 8.52) among non-diabetic. The difference in the median PSV of central 
retinal vein across study group was statistically significant (P value <0.001). 
Among the diabetic retinopathy group median EDV of central retinal vein was 3.90 (IQR 
2.90 to 5.20), it was 3.90(IQR 3 to 4.77) among diabetic without retinopathy, and 3.55 
(IQR 3.17 to 4.32) among non-diabetic. The difference in the median EDV of central 
retinal vein across study group was statistically not significant (P value 0.727). 
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Among the, diabetic retinopathy group median PI of central retinal vein was 0.74 (IQR 
0.49 to 0.98), it was 0.60(IQR 0.43 to 0.88) among diabetic without retinopathy, and 0.47 
(IQR 0.38 to 0.75) among non-diabetic. The difference in the median PI of central retinal 
vein across study group was statistically significant (P value 0.001) 
Among the, diabetic retinopathy group median RI of central retinal vein was 0.50 (IQR 
0.39 to 0.60), it was 0.46(IQR 0.35 to 0.58) among diabetic without retinopathy, and 0.37 
(IQR 0.30 to 0.5) among non-diabetic. The difference in the median RI of central retinal 
vein across study group was statistically significant (P value 0.002) 
As per study by Sood, S., et al.
[69] 
the PSV, EDV and RI of Central Retinal Vein among 
people affected by diabetic retinopathy were 14.28 ± 11.21,5.64 ± 3.81 and 0.67 ± 0.10 
respectively. This study had not compared the doppler parameters with non-diabetic 
retinopathy/ control groups as in our study. But in the diabetic population with 
retinopathy PSV and RI values were almost similar to current study, but EDV values 
appeared to be considerably lower than the current study.  
Dimitrova, G., et al.
[53]
 have studied, retro bulbar circulatory parameters in type 2 diabetic 
patients with and without diabetic retinopathy (DR) during prospective follow up. In this 
study, among 18 patients who developed DR progression showed significantly increased 
central retinal vein PSV ( 5.6 (3.5-9.1) p = 0.003), EDV ( 3.4 (2.3-4.4) p = 0.04), and RI ( 
0.43 (0.20-0.56) p = 0.02) at the final measurement compared to the initial measurement 
(PSV = 4.6 (3.2-7.0); EDV = 3.0 (2.3-3.7); RI = 0.40 (0.17-0.52)). Circulatory parameters 
in the central retinal artery and the posterior ciliary artery did not alter significantly after 
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progression of DR. 17 patients were without DR progression and they did not show any 
significant differences in the measured circulatory parameters on entry compared to the 
final measurement. The authors of this study suggest that the initial changes in the retro 
bulbar circulation during DR progression occur in the central retinal vein. 
Basturk, T., et al. 
[70]
have evaluated only resistive Index (RI) values of orbital arteries by 
using the colour Doppler imaging (CDI) in type II diabetes mellitus (DM) patients with 
microalbuminuria. In this study, the DM patients with microalbuminuria were grouped 
into two: group 1 consisted of patients with retinopathy (n = 51) and group 2 consisted of 
patients without retinopathy (n = 40). Healthy subjects constituted group 3 (n = 27). 
Compared to diabetic group 2, group 1 had significantly higher mean RIs of OA, CRA, 
PCA, and HbA1c levels (p < 0.001 for all). Besides, there were no statistical differences 
in mean RIs of OA, CRA, and PCA between the control group and group 2 (p = 1.0; p = 
0.44; p = 0.67, respectively). Mean RIs of OA and PCA were significantly correlated 
with age in group 1 (r = 0.549, p < 0.001; r = 0.407, p = 0.003, respectively). Mean RI of 
CRA was significantly correlated with the duration of diabetes and age in group 1 (r = 
0.296, p = 0.035; r = 0.486, p < 0.001, respectively). The authors have concluded that, RI 
might be a useful marker for early diagnosis and follow-up of diabetic retinopathy, and 
orbital RI assessment would be beneficial for diabetic patients with retinopathy. 
Similar to our study, Karami, M., et al.
[71]
 compared orbital blood flow velocities using 
Doppler and gray-scale sonography in patients with DR, and to compare the results with 
those of their non-diabetic and diabetic peers without retinopathy. Similar to our study, 
compared with healthy controls, the age-adjusted resistive Index of the ophthalmic artery 
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were significantly higher in patients with DR (p < 0.05). After further adjustment for age, 
gender, HbA1c, fasting plasma glucose, blood pressure, BMI, cholesterol, HDL, LDL, 
and triglycerides, only the resistivity index of the ophthalmic artery and the central retinal 
vein remained significantly higher in patients with DR compared with healthy controls.  
Similar to our study, Krasnicki, P., et al.
[57] 
have studied 3 groups: group I--control group, 
group II--type 2 diabetes patients without diabetic retinopathy, group III--type 2 diabetes 
patients with non proliferative diabetic retinopathy. Peak systolic blood velocity (PSV) 
and end-diastolic blood velocity (ESV) in ophthalmic artery (OA) in diabetic patients 
were significantly lower in comparison to the control group. Peak systolic blood velocity 
(PSV) and end-diastolic blood velocity (ESV) in central retinal artery (CRA) were 
significantly lower only in patients with diabetic retinopathy. Diabetes duration was 
significantly longer in group III in comparison to group II. Based on the findings, the 
authors concluded that Blood flow in ophthalmic artery is decreased in patients with 
diabetes. Reduction of blood flow in central retinal artery and short posterior ciliary 
arteries can be significant in the development of diabetic retinopathy. 
CORRELATION OF HBA1C AND DOPPLER PARAMETERS: There was a weak 
positive correlation between HbA1c and PSV (rs value: 0.048, P value 0.601). There was 
a weak negative correlation between HbA1c and EDV (rs value: -0.132, P value 0.145). 
There was a weak positive correlation between HbA1c and PI (rs value: 0.204, P value 
0.024). There was a weak positive correlation between HbA1c and RI (rs value: 0.147, P 
value 0.106). There was a weak negative correlation between HbA1c and PSV (rs value: -
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0.025, P value 0.781). There was a weak negative correlation between HbA1c and EDV 
(rs value: -0.115, P value 0.208). There was a weak positive correlation between HbA1c 
and PI (rs value: 0.055, P value 0.547). There was a weak positive correlation between 
HbA1c and RI (rs value: 0.107, P value 0.238).There was a weak positive correlation 
between HbA1c and PSV (rs value: 0.069, P value 0.449).There was a weak positive 
correlation between HbA1c and EDV (rs value: 0.0.034, P value 0.711). There was a 
weak positive correlation between HbA1c and PI (rs value: 0.060, P value 0.512).There 
was a weak positive correlation between HbA1c and RI (rs value: 0.007, P value 0.939) 
Sood, S., et al
.[69]
 concluded that, alterations in the retro bulbar arterial circulation do not 
seem to predict the progression of diabetic retinopathy and development of proliferative 
disease in NIDDM patients. The retro bulbar arterial circulation appeared to be affected 
in all diabetics and the changes appear to progress with increasing duration in all 
diabetics. Certain other factors seem to play a role in progression of DR.  
Diabetes duration was the parameter, which had consistently demonstrated a strong 
association with the changes in orbital blood flow parameters in many previous studies. 
Basturk, T., et al.
[70] 
have reported Mean RI of CRA to be  significantly correlated with 
the duration of diabetes and age in patients with DR (r = 0.296, p = 0.035; r = 0.486, p < 
0.001, respectively). Study by Krasnicki, P., et al.
[57] 
also have reported similar findings. 
This relationship has not been evaluated by our study.  
As in our study, Meng, N., et al
.[73]
 have done Color Doppler Imaging Analysis of 
Retrobulbar Blood Flow Velocities in 3 groups: group 1, diabetes without retinopathy 
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versus control; group 2, DR versus control; and group 3, diabetic without retinopathy 
versus DR. In group 1, eyes without retinopathy had a significant increase in ophthalmic 
artery PSV (P = .002) and significant reductions in central retinal artery PSV and EDV (P 
= .002; P = .007, respectively). A significant increase in ophthalmic artery RI (P = .02) 
was found in eyes without retinopathy. In group 2, central retinal artery PSV and EDV in 
eyes with retinopathy decreased significantly (P < 0.00001). Ophthalmic artery RI was 
significantly higher in eyes with retinopathy than controls (P = .0008). In group 3, 
ophthalmic artery PSV was lower in eyes with retinopathy (P= .04) than eyes without, 
and central retinal artery PSV and EDV decreased significantly (P = .004; P < .00001) in 
eyes with retinopathy compared to eyes without. Differences in ophthalmic and central 
retinal artery RIs were also found in eyes with retinopathy (P = .05; P < .00001). In one 
of the early studies, Mendivil, A., et al
.[47]
 have compared blood flow velocity in ocular 
vessels (ophthalmic artery, posterior ciliary arteries, central retinal vessels, and vortex 
veins) of 25 patients with proliferative diabetic retinopathy and 30 age matched normal 
subjects using a colour Doppler imaging unit. The diabetic patients had lower blood 
velocities than the volunteers. There were significant differences in ophthalmic artery; 
systolic (p < 0.01), diastolic (p < 0.001), mean velocity (p < 0.05), and central retinal 
artery; systolic (p < 0.001), diastolic (p < 0.001), mean velocity (p < 0.05). No significant 
correlations were found between age and blood velocities.  
 Ocular blood flow velocity was decreased in diabetic patients with retinopathy with 
increased PI and RI.                                
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9. LIMITATIONS OF THE STUDY 
However our study had some limitations which are listed below 
1. Lack of statistical significance of differences in many quantitative parameters 
across the study groups may be attributed to relatively smaller sample of the study.  
2. The  role of positive or negative confounding effect by various demographic and 
clinical variables could not be tested due to smaller sample size 
3. Generalization of the study findings was limited, as the study was conducted in a 
single centre with limited catchment area 
4.  There are many different results relating to the association of blood flow 
velocities and diabetic retinopathy in the literature.  
5. The interpretation of these data is complicated by the demographic variability in 
the patients, the methodological problems related to the outcome measures in these 
studies, and their subsequent analyses. 
6. Colour doppler Imaging is operator-dependent nature of ultrasonography although 
it is non-invasive, easily performed, and confidential method for evaluating CDI 
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10. SUMMARY 
 The current study had compared the ocular blood flow parameters, among diabetic 
patients, with and without retinopathy and non-diabetic healthy control group.  
 The average age of all the three study groups was about 50 years, with no 
statistically significant difference across the study groups.  
 In both the diabetes groups (with and without retinopathy) the proportion of males 
was slightly higher, as compared to equal number of males and females among 
control group. But the gender composition across the study groups, showed no 
statistically significant difference.  
 Among the people with diabetic retinopathy, majority (70.9%) participants had 
mild DR. The proportion of moderate and severe DR was 25.5% and 3.6% 
respectively.  
 Even though the systolic blood pressure was slightly higher and showed 
statistically significant difference in healthy controls, as compared to other two 
groups, the difference doesn’t appear to be of any clinical significance. No 
clinically significant difference was found in diastolic blood pressure across three 
groups.  
 All the glycemic control parameters (fasting blood sugar, post prandial blood 
sugar and HbA1c) were significantly higher in diabetes with retinopathy group, as 
compared to diabetes without retinopathy, which had comparatively higher values 
than normal healthy controls. 
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 Among, ophthalmic artery doppler parameters, PSV had shown no statistically 
significant difference across the groups (P value 0.347). EDV was lowest in DR 
group, followed by non-DR group and was higher in healthy controls (P value 
<0.001). The PI was highest in DR group, followed by no DR group and least 
among healthy controls (P value <0.001). The RI of ophthalmic artery was also 
highest among DR group and showed declining trend in non DR and healthy 
controls (P value <0.001) 
 Among Central Retinal artery parameters also PSV did not show any statistically 
significant difference. EDV of Central Retinal artery was much lower in DR 
group, as compared to non-DR group and healthy controls. PI and RI of Central 
Retinal artery also showed declining trend from DR group to non-DR group and 
healthy controls (P value <0.001).  
 Among the, central retinal vein parameters PSV was highest in DR group and 
showed declining trend in non-DR group and (healthy controls. (P value <0.001). 
EDV of both DR and non-DR groups was similar and even though, it was slightly 
lower in control group, the difference was statistically not significant P value 
0.727). The PI and RI values of central retinal vein were highest in DR group, 
followed by non DR group and lowest in healthy controls (P value <0.05)  
 None of the ocular blood flow parameters had shown statistically significant 
correlation with HbA1c values among diabetic population.  
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11. CONCLUSION 
1. This study concludes that Orbital Colour Doppler Imaging has the potential to 
provide useful information related to altered ocular blood flow even before the 
appearance of Diabetic retinopathy thereby enabling early diagnosis of diabetic 
retinopathy and early intervention. 
2. The findings of our study suggest a need for large-scale studies to derive a cut off 
value in the Doppler indices to identify the Diabetics who are at risk of developing 
retinopathy. Further the study of association of ocular blood flow parameters with 
other micro and macro vascular complications in diabetics may help in identifying 
subjects with high risk of developing complications. 
3. This study also opens up the area of research required in assessment of treatment 
response with the utility of colour Doppler imaging in Diabetic Retinopathy. 
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43 ND THENMOZHI 40 F 170 62 110 70 99 108 4.1 30 7.7 1.523 0.745 9.4 4.2 0.796 0.547 4.8 4.2 0.116 0.111 normal
44 ND ANGEL 30 F 166 62 110 70 89 106 4.5 49.6 8.9 1.075 0.82 13.9 4 1.312 0.716 8.5 5.6 0.422 0.341 normal
45 ND AMULU 40 F 164 58 110 80 80 120 4.6 18.7 4 1.366 0.784 25 5.1 1.538 0.794 11 6.8 0.475 0.383 normal
46 ND AMALA 60 F 168 59 120 80 102 128 4.6 24.3 6.5 1.297 0.731 17.8 4 1.611 0.776 8.2 4.9 0.523 0.4 normal
Weight
S. 
No.
Group AGE SEX HeightNAME
CENTRAL RETINAL ARTERY CENTRAL RETINAL VEIN
FUNDOSCOPYSBP DBP FBS PPBS HbA1C OAEDV OAPI OARI
OPHTHALMIC 
ARTERY
OAPSV CRAPSV CRAEDV CRAPI CRARI CRVPSV CRVEDV CRVPI CRVRI
Weight
S. 
No.
Group AGE SEX HeightNAME
CENTRAL RETINAL ARTERY CENTRAL RETINAL VEIN
FUNDOSCOPYSBP DBP FBS PPBS HbA1C OAEDV OAPI OARI
47 ND MOHAMMMED BASHA 45 M 166 54 110 80 101 130 4.8 32.3 5.9 1.713 0.817 9.6 2.3 1.363 0.761 8.8 5.1 0.587 0.423 normal
48 ND BASHEERA 47 F 162 55 110 60 92 118 4.9 29.4 8 1.353 0.727 10.9 1.6 1.854 0.853 6 2.2 0.927 0.638 normal
49 ND EZHUMALAI 56 M 160 49 110 70 98 133 4.8 35.5 8.9 1.667 0.749 9.5 2.8 1.274 0.705 4.7 2.8 0.498 0.4 normal
50 ND ELIZABETH 50 F 149 50 110 70 90 113 4.2 30.4 9.2 1.37 0.696 7.7 1.4 1.559 0.823 5.4 4.3 0.221 0.2 normal
51 ND ALFRINA 23 F 148 52 110 78 102 128 4.8 30.1 7.5 1.503 0.75 11.6 3.1 1.433 0.735 9.3 5.5 0.562 0.623 normal
52 ND DHANAPAL 39 M 152 60 120 78 108 123 5.1 28.9 6.9 1.546 0.761 14.8 5.2 1.14 0.851 7.2 5.5 0.775 0.653 normal
53 ND DEVARAJAN 60 M 148 52 110 60 82 118 4.9 32.1 8.2 1.478 0.744 12.7 6.5 0.732 0.486 9.5 5.7 0.545 0.611 normal
54 ND NAGENDRAN 56 M 152 60 110 70 88 120 4.4 31.8 10.5 1.21 0.67 10.5 3.8 1.11 0.638 5.5 3.2 0.58 0.418 normal
55 ND NOORJAHAN 45 F 159 64 110 80 92 128 4.5 28.4 7.5 1.445 0.735 11.8 3.8 1.238 0.677 4.8 3.5 0.33 0.27 normal
56 ND NARASIMMAN 50 M 160 65 110 70 98 132 4.9 31.1 7.6 1.5 0.755 10.3 3.8 1.09 0.631 5.1 3.5 0.397 0.313 normal
57 ND VIDHYA 45 F 160 49 110 60 108 124 4.7 29.8 7.5 1.496 0.748 9.9 3.8 1.04 0.616 5.2 3.5 0.418 0.326 normal
58 ND VARADHAN 55 M 155 52 110 70 118 128 4.5 30.2 7.5 1.507 0.751 11.1 3.5 1.26 0.684 5.1 3.2 0.496 0.171 normal
59 ND MAHALAKSHMI 40 F 149 52 110 60 108 125 4.5 31 6.8 1.628 0.78 10.9 3.8 1.151 0.651 5.1 3.9 0.279 0.235 normal
60 ND MEERAN 45 M 155 55 110 70 110 138 4.8 29.7 7.2 1.53 0.757 10.8 2.9 1.482 0.731 4.8 3.2 0.428 0.333 normal
61 ND VENDA 60 F 162 59 118 72 98 123 4.5 29.8 7.6 1.48 0.744 10.9 3.9 1.123 0.642 4.9 3.5 0.353 0.285 normal
62 ND MEENA 40 F 165 55 120 80 88 113 4.2 31.2 7.6 1.525 0.756 10.5 3.2 1.295 0.695 5.2 2.8 0.666 0.461 normal
63 ND MEERA 55 F 159 62 110 80 92 113 4.1 29.7 7.2 1.53 0.762 10.1 3.6 1.127 0.643 4.9 3.6 0.322 0.17 normal
64 ND MUTHU 60 M 160 60 110 70 88 133 4.9 30.1 7.1 1.558 0.764 10.9 3.2 1.336 0.706 4.7 3.9 0.192 0.17 normal
65 ND RAJESH 55 M 155 62 120 80 92 131 4.5 31.2 7.3 1.565 0.766 9.9 4.1 0.961 0.585 4.3 3.1 0.342 0.279 NORMAL
66 ND SANKARAN 45 M 168 68 120 80 98 124 5.2 29.6 7.2 1.527 0.756 10.5 3.8 1.11 0.538 5.1 3.4 0.428 0.333 normal
67 ND RADHA 49 F 162 42 110 60 88 116 4.1 30.4 7.3 1.54 0.759 10.9 3.5 1.24 0.678 5.1 3.8 0.307 0.254 normal
68 ND MARY 50 F 158 52 110 70 90 125 4.9 30.1 7.1 1.558 0.764 10.8 3.2 1.32 0.703 4.5 2.9 0.47 0.355 normal
69 ND MAHISHA 50 F 165 40 110 80 78 109 4.2 31.8 8.1 1.46 0.745 11.1 3.6 1.229 0.675 4.8 3.6 0.3 0.25 normal
70 ND KANDHAN 60 M 164 58 110 70 92 118 4.3 31.3 7.5 1.54 0.76 11.1 3.8 1.171 0.657 5.1 3.5 0.396 0.313 normal
71 ND VELAYUTHAM 50 M 163 59 110 80 89 107 4.2 30.8 7.2 1.54 0.766 9.9 2.8 1.22 0.717 5.1 3.5 0.41 0.313 normal
72 ND VEERA 45 M 165 52 110 70 92 117 4.3 30.4 7.1 1.567 0.766 10.9 3.5 1.24 0.678 4.9 2.9 0.56 0.408 normal
73 ND MARIYAMMAL 50 F 162 52 110 80 98 124 4.4 29.9 7.2 1.537 0.759 11.1 3.2 1.35 0.711 5.3 3.7 0.377 0.301 normal
74 ND SAROJA 50 F 166 54 110 60 101 128 5.2 30.3 7.5 1.509 0.752 11.3 3.5 1.27 0.69 4.8 3.5 0.33 0.27 normal
75 ND LATHA 46 F 168 59 110 70 99 128 4.5 29.7 7.1 1.54 0.76 11.2 3.5 1.27 0.687 4.8 3.6 0.3 0.25 normal
76 ND MEGHANATHAN 50 M 164 58 110 60 98 123 4.6 31.2 8.3 1.566 0.766 10.1 3.2 1.254 0.683 5.1 3.5 0.397 0.313 normal
77 ND RAVI 45 M 167 64 120 80 102 129 4.9 30.1 7.1 1.558 0.764 10.1 2.9 1.35 0.72 5.2 3.5 0.418 0.326 normal
78 ND RAGHAVAN 46 M 165 63 110 70 108 128 4.3 31.1 7.5 1.536 0.758 11.3 3.2 1.37 0.716 5.1 3.2 0.5 0.372 normal
79 ND SUBHA 46 F 165 53 110 60 101 126 4.1 31.4 8.2 1.5 0.738 10.3 4.1 1.006 0.601 5.1 3.9 0.27 0.235 normal
80 ND RAMESH 50 M 168 59 110 60 108 129 4.2 32.1 8.3 1.469 0.741 11.5 3.9 1.18 0.66 5.6 3.9 0.381 0.303 normal
81 ND VEERAPPAN 56 M 164 60 120 80 106 123 4.5 30.5 7.7 1.49 0.747 11.1 3.2 1.362 0.711 4.9 2.5 0.727 0.489 normal
82 ND RAJA 48 M 167 61 120 70 81 118 5 31.6 7.2 1.594 0.772 10.9 3.9 1.12 0.642 4.8 3.5 0.333 0.27 normal
83 ND VALLI 52 F 158 62 110 70 98 110 4.9 30.2 6.9 1.595 0.771 11.3 4.5 1.005 0.681 5.2 3.6 0.387 0.307 normal
84 ND LAKSHMI 61 F 152 55 110 60 88 115 4.5 31.2 6.8 1.637 0.782 11.5 3.5 0.568 0.695 5 3.2 0.473 0.36 normal
85 ND NALINI 45 F 162 58 120 70 92 128 4.6 32.6 7.8 1.55 0.76 11.1 3.6 1.22 0.675 5.2 3.5 0.418 0.326 normal
86 ND MARY 50 F 152 49 110 70 81 109 4.5 33.6 8.1 1.536 0.666 11.2 3.9 1.15 0.651 5 3.5 0.375 0.3 normal
87 ND SANKAR 49 M 166 55 120 80 87 118 4.6 30.8 7.5 1.532 0.756 10.5 3.1 1.33 0.704 4.5 3 0.428 0.333 normal
88 ND SAHAYAM 58 M 158 59 110 80 102 124 4.1 31.2 7.5 1.538 0.759 10.8 3.8 1.141 0.648 5.2 3.5 0.418 0.325 normal
89 ND ADHILAKSHMI 65 F 157 58 120 80 98 126 4.8 31.1 7.6 1.525 0.755 10.8 4 1.086 0.629 5 3.6 0.344 0.28 normal
90 ND RADHA 48 F 166 60 110 70 87 119 4.5 30.5 7.5 1.517 0.754 10.2 3.4 1.201 0.666 5.1 3.5 0.397 0.313 normal
OAPSV OAEDV OAPI OARI CRAPSV CRAEDV CRAPI CRARI CRVPSV CRVEDV CRVPI CRVRI
1 DNR AMULU 36 F 168 75 108 78 128 168 6.9 28.3 7.4 1.456 0.738 9.1 2.3 1.619 0.747 7.6 6.3 0.225 0.165 normal
2 DNR VALLIYAMMAL 56 F 161 56 118 80 90 118 6.6 39.7 9.2 1.685 0.768 12 5.9 0.504 0.747 12.7 8 0.369 0.509 normal
3 DNR DURAIRAJ 56 M 156 92 118 80 264 280 7.5 27.8 2.9 2.644 0.894 12.1 3.1 1.34 0.42 9.3 4.2 0.89 0.54 normal
4 DNR CHINNAMMAL 67 F 162 65 120 80 220 262 7.8 33 6.8 1.767 0.794 14.3 4.3 1.32 0.699 10.8 4.3 1.05 0.606 normal
5 DNR GANESAN 70 M 165 72 118 86 118 180 6.8 20 3.7 1.83 0.814 8.5 2 1.5 0.761 13.5 3.1 2.3 0.774 normal
6 DNR SARAVANAN 35 M 168 41 110 80 134 313 7.1 21.2 5.1 1.663 0.758 7.3 2.5 1.051 0.658 5.8 2.4 0.59 0.586 normal
7 DNR PRASATH 50 M 170 95 112 80 184 322 7.5 30.9 6 1.445 0.805 9.6 2.2 1.732 0.772 9.4 3 1.179 0.684 normal
8 DNR RAVI 50 M 164 65 120 80 419 508 8.2 45.3 10.5 1.665 0.769 9.4 1.6 1.414 0.829 18.5 9.5 0.834 0.486 NORMAL
9 DNR MUNUSAMY 57 M 160 64 118 78 287 312 7.5 21.2 4 1.907 0.814 13.9 2.4 1.703 0.826 15.3 6.1 1.034 0.605 normal
10 DNR GOVINDHASAMY 64 M 173 72 122 80 156 202 7.3 32.4 5.3 1.88 0.838 12.7 2.3 1.799 0.819 14.1 8 0.541 0.431 NORMAL
11 DNR RADHAKRISHNAN 50 M 159 37 118 80 312 342 8.2 34 6.3 2.048 0.814 6.5 2.1 1.294 0.676 9.4 4.1 0.848 0.566 normal
12 DNR GNANASAMBANDHAM 51 m 161 47 120 82 206 254 7.2 24.1 3.1 2.284 0.87 10.7 3.8 1.111 0.643 8.5 4.9 0.591 0.416 normal
13 DNR JAYACHANDRAN 25 M 174 54 118 70 366 402 8.1 26.6 7.1 1.503 0.735 14.4 3.1 1.967 0.785 7.1 3.8 0.78 0.469 normal
14 DNR VENKATACHALAPATHY 39 M 168 64 120 80 472 512 8 34.6 7 1.761 0.798 18.3 2.6 1.892 0.86 5.6 3.7 0.421 0.344 normal
15 DNR PATCHAIAPPAN 56 m 163 57 120 60 329 363 7.8 36.9 7.2 1.882 0.804 9.2 2.6 1.207 0.712 7.8 4.8 0.42 0.384 normal
16 DNR BHARATH 22 M 169 39 110 60 220 284 6.8 28 4.2 2.227 0.85 15.9 6.6 0.892 0.583 5.2 3 0.548 0.423 normal
17 DNR KUPPAN 55 M 168 49 120 86 225 300 7.2 29.3 5.8 1.549 0.807 28.4 4.5 1.75 0.843 6.7 1.9 1.47 0.722 normal
18 DNR RAVI 52 M 162 70 118 82 210 292 7.5 31.8 8.8 1.454 0.724 9.1 5.8 0.46 0.367 8.5 2.3 1.27 0.725 normal
19 DNR KUPPU 58 F 142 75 120 78 302 356 7.9 36.9 7.9 1.655 0.785 13.9 5.8 0.826 0.583 9.7 6 0.516 0.38 normal
20 DNR UTHRA 25 f 147 64 110 60 234 331 14.7 29.8 6.5 1.681 0.781 9.8 1.6 2.102 0.84 8.7 5.7 0.447 0.341 normal
21 DNR FATHIMA NOORA 25 F 160 45 110 80 263 284 7.5 33.2 6.1 2.28 0.815 9.8 2.3 1.881 0.767 4.4 3 0.348 0.316 normal
22 DNR RANI 35 F 144 56 110 80 238 302 7.5 17 4.3 1.505 0.746 14.1 3.9 1.95 0.725 10.2 4.1 1.318 0.595 NORMAL
23 DNR LAKSHMI 46 F 162 72 110 80 120 156 6.5 22.2 4.6 1.8 0.794 11.1 4.6 0.899 0.587 8.1 4.2 0.769 0.478 normal
24 DNR SEKAR 55 M 160 52 120 84 422 560 8 16 5.2 1.229 0.675 10.2 2.7 1.445 0.736 6.8 3.3 0.84 0.514 normal
25 DNR SAGADEVAN 39 M 167 43 110 70 303 368 7.5 27.1 7.4 1.554 0.726 9.7 2.7 1.53 0.716 6.4 3.9 0.587 0.388 normal
26 DNR SAKTHIDASAN 34 M 162 60 118 80 224 268 7 28.7 6.4 1.858 0.778 10.4 1.9 1.88 0.815 10.9 4 1.229 0.632 normal
27 DNR RASOOL BEE 30 F 158 72 110 70 147 182 6.9 59.2 11.3 2.2 0.809 5.8 1.4 1.408 0.76 3.5 1.7 0.645 0.5 normal
28 DNR BHARATHI 42 F 162 73 120 80 195 271 8.5 38.4 10.6 1.371 0.723 7 1 1.858 0.86 5.3 3.9 0.297 0.259 normal
29 DNR SURESH 56 M 160 58 120 78 180 220 7.5 21.7 6.4 1.381 0.703 12.6 5.1 0.91 0.596 8.4 4.6 0.677 0.447 normal
30 DNR JAYARAMAN 60 M 159 60 120 78 151 220 7 41.3 8.8 1.739 0.788 15.4 3.9 1.401 0.747 8 5 0.465 0.372 normal
31 DNR JAYANTHI 60 F 161 68 110 80 149 286 7.1 38.1 8.1 1.73 0.787 16.9 4.9 1.292 0.709 10.2 4.9 0.882 0.591 normal
32 DNR GANAPATHY 52 M 160 62 120 62 83 110 5.2 30.1 6.4 1.771 0.786 17 3.4 1.559 0.798 7.7 5.2 0.381 0.316 normal
33 DNR KULANDAIRAJ 65 M 162 58 120 70 183 208 6.8 34.5 6.4 1.705 0.811 16.7 2.4 1.793 0.859 8.4 5.5 0.433 0.344 normal
34 DNR AMEENA BEE 40 F 161 78 120 70 302 385 7.1 31.9 8.7 1.487 0.727 11.3 2.7 1.349 0.766 6.2 1.8 1.207 0.714 normal
35 DNR LAKSHMI 47 F 156 65 120 78 225 246 7.3 31.2 8.9 1.326 0.713 4.9 1.8 1.065 0.644 5.6 3.7 0.439 0.348 normal
36 DNR CHANDRULAKSHMI 45 F 160 58 110 80 208 226 7.6 35.8 5.1 1.987 0.859 17.2 2.7 1.826 0.846 15.1 5.4 1.288 0.642 normal
37 DNR ABITHA 18 M 165 52 110 60 261 373 7.1 39.9 11.1 1.516 0.722 10.7 2.6 1.183 0.754 6 3.9 0.419 0.344 normal
38 DNR ARUNA 55 F 162 49 120 80 208 246 7.7 38.6 8.5 1.787 0.78 8.8 3.4 0.901 0.619 5.1 4.5 0.107 0.105 normal
39 DNR ABIRAMI 60 F 160 58 110 80 202 253 7.5 32.8 8 1.651 0.756 10 3.3 1.19 0.673 4.2 3.1 0.306 0.273 normal
40 DNR ANNAKILI 47 F 148 49 120 80 266 288 7.5 20 5.3 1.655 0.736 8.5 2 1.477 0.769 3.7 2.9 0.233 0.214 normal
41 DNR VALARMATHY 50 F 163 61 120 80 283 362 7.3 31.4 7.6 1.91 0.756 9.5 2.5 1.439 0.74 7.6 4.4 0.604 0.425 normal
42 DNR MANI 60 M 160 56 120 70 280 303 7.5 26.7 4.8 2.095 0.82 13.4 2.6 1.694 0.805 5.4 4.2 0.251 0.226 normal
43 DNR BALAJI 44 M 172 68 110 70 199 243 7.5 25.1 3.2 2.081 0.871 6.6 1.3 1.918 0.803 4.8 2.2 0.95 0.527 normal
44 DNR BALAN 50 M 168 70 110 60 200 268 7.1 32.5 5.8 1.837 0.823 4.1 1.2 1.449 0.7 3.3 1.5 0.868 0.542 normal
45 DNR BABU 55 M 170 66 110 70 213 246 7.3 33 7.1 1.642 0.784 4 1.2 1.359 0.712 4.2 1.8 0.938 0.581 normal
46 DNR BABY 50 F 168 59 110 60 238 260 7.4 21.7 3.4 1.947 0.845 4.4 1.2 1.401 0.734 4.9 2.2 0.926 0.558 normal
Weight
S. 
no.
Group AGE SEX HeightNAME
CENTRAL RETINAL ARTERY CENTRAL RETINAL VEIN
FUNDOSCOPYSBP DBP FBS PPBS HbA1C
OPHTHALMIC ARTERY
OAPSV OAEDV OAPI OARI CRAPSV CRAEDV CRAPI CRARI CRVPSV CRVEDV CRVPI CRVRI
Weight
S. 
no.
Group AGE SEX HeightNAME
CENTRAL RETINAL ARTERY CENTRAL RETINAL VEIN
FUNDOSCOPYSBP DBP FBS PPBS HbA1C
OPHTHALMIC ARTERY
47 DNR MADAN KUMAR 32 M 160 45 110 70 357 392 7.3 31.3 6 1.922 0.809 15.4 3.8 1.612 0.755 14 4.2 0.823 0.698 normal
48 DNR MOHAN 38 M 165 50 110 80 303 342 7.4 20.8 4.6 1.856 0.773 13.6 3.8 1.294 0.721 8.7 4.7 0.719 0.462 normal
49 DNR ANANDHAN 64 M 172 60 110 70 308 392 7.5 30.3 7.5 1.355 0.745 9 2 1.389 0.78 7.9 4.3 0.599 0.458 NORMAL
50 DNR AMUDHA 60 F 170 62 110 60 302 363 7.8 36.4 6.6 1.388 0.75 11.9 2.8 1.444 0.761 9.7 5.4 0.585 0.44 normal
51 DNR DHARMAN 60 M 170 60 110 60 318 342 7.3 19.8 5.1 1.444 0.743 18.2 2.8 1.822 0.848 9 4.6 0.674 0.487 normal
52 DNR DHARANI 60 F 168 59 110 70 323 348 7.2 19.4 3.7 7.694 0.804 19.3 3.8 1.569 0.803 10.1 5.6 0.577 0.45 normal
53 DNR BHARATH 22 M 170 39 110 80 246 273 6.8 50.2 8.6 1.969 0.828 12.3 2 1.64 0.838 7.8 5 0.281 0.356 normal
54 DNR BHAVANI 30 F 168 45 110 70 232 264 7.5 32 8.1 1.463 0.745 9.2 2 1.492 0.776 4.1 2.6 0.467 0.367 normal
55 DNR SHANKAR 48 M 171 82 140 80 273 384 8.1 32.7 9.3 1.318 0.714 13.9 2.7 1.69 0.806 7.5 3.7 0.761 0.5 normal
56 DNR SAVITHIRI 50 F 170 76 12 80 280 323 7.9 25.7 5.9 1.585 0.769 16.9 3.4 1.739 0.798 6.2 3.7 0.533 0.395 normal
57 DNR SAROJA 55 F 168 62 120 86 263 338 7.8 17.5 3.4 1.539 0.808 17.8 3.3 1.944 0.817 7 4.1 0.584 0.419 normal
58 DNR SHANMUGAM 60 M 167 64 120 70 243 282 7.6 38.5 9.6 1.436 0.75 16.6 2.1 2.351 0.872 7.8 2.6 0.364 0.659 normal
59 DNR VASANTHA 50 F 165 75 120 80 230 256 6.9 34.9 6.9 1.596 0.801 8.8 3.7 0.99 0.581 5.7 4.5 0.215 0.2 normal
60 DNR VIVEGAN 56 M 169 65 110 70 193 246 7.2 36 12.8 1.163 0.645 8 1.8 1.45 0.775 5.2 3.5 0.387 0.326 normal
61 DNR MUNUSAMY 56 M 162 61 130 80 260 292 7.4 29.5 8.1 1.789 0.725 8.5 2 1.385 0.766 5.2 3.3 0.432 0.351 normal
62 DNR MARIAPPAN 60 M 165 64 120 80 243 264 7.3 34.1 8.4 1.436 0.752 8.4 7.3 1.769 0.85 6.1 3.7 0.547 0.397 normal
63 DNR MARY 65 F 160 58 120 80 193 224 6.9 30.5 8.6 1.253 0.717 9.5 1.7 1.586 0.825 6.9 3.6 0.768 0.478 normal
64 DNR MANGAMMAL 60 F 162 56 110 70 180 218 6.8 29.9 8.6 1.252 0.713 9.7 1.5 1.625 0.844 6.8 3.7 0.653 0.461 normal
65 DNR PACHAIYAPPAN 54 M 172 72 100 70 237 283 7.8 32.4 9.6 1.325 0.703 6.2 1.1 1.374 0.826 8 3.2 1.164 0.6 normal
66 DNR PANDIYAN 60 M 170 68 120 80 232 264 7.6 31.4 8.2 1.433 0.738 10.1 2 1.415 0.804 8.3 3 1.415 0.641 normal
67 DNR PETCHIYAMMAL 65 F 166 62 110 80 202 246 7.1 29.7 7.1 1.498 0.76 7.1 1 1.735 0.867 5.9 2.5 0.855 0.582 normal
68 DNR PREMA 65 F 164 65 110 70 164 203 7.2 24.2 4.8 1.632 0.8 6.3 1 1.876 0.849 5.1 2 1.196 0.608 normal
OAPSV OAEDV OAPI OARI CRAPSV CRAEDV CRAPI CRARI CRVPSV CRVEDV CRVPI CRVRI
1 1 DR sulochana 47 F 162 68 124 82 156 204 8.8 47.2 8.1 2.25 0.829 11.2 2.2 1.34 0.802 8.1 2 1.869 0.753 MILD
2 2 DR thulasi 43 F 151 60 120 80 172 255 10.1 56.7 10 1.982 0.823 11.1 2.2 1.348 0.802 6.6 2 1.533 0.696 MILD
3 3 DR vasanthi 48 F 160 68 110 72 208 256 7.9 47.2 8.1 2.253 0.802 26.6 6.9 1.245 0.739 11.6 6.9 0.492 0.4 MODERATE
4 4 DR RANI 50 F 158 64 128 88 173 256 7.5 37.6 7.6 2.74 1.204 22.1 7.3 1.345 0.669 6.4 2 1.419 0.687 MILD
5 5 DR RASHIDA BEGUM 46 F 156 58 110 60 120 230 7.6 30.1 3.2 2.15 0.893 12.9 3 1.52 0.767 7.3 3.2 0.989 0.565 MILD
6 6 DR NAGALAKSHMI 56 F 165 68 120 76 112 207 7.2 28.7 8 1.228 0.72 16.2 1.7 1.29 0.709 7 1.7 1.814 0.753 MILD
7 7 DR CHELLAMUTHU 42 m 151 45 114 78 183 253 7.5 32.9 5 2.23 0.848 21 3.2 2.019 0.849 5.1 4.1 0.236 0.207 mild
8 8 DR BALU 56 M 163 65 110 70 199 264 7.5 38.3 5.4 2.284 0.86 11.6 1 1.472 0.862 8.7 5.1 0.526 0.41 MILD
9 9 DR VAIRAM 45 F 165 70 112 78 198 226 7.1 31.7 5.2 1.876 0.835 21.3 3.3 2.324 0.845 9.3 6 0.402 0.345 MILD
10 10 DR GANESAN 65 M 166 68 120 80 201 262 7.1 47 5.1 2.4 0.891 9.9 2.2 1.674 0.778 13.3 5.8 0.981 0.562 MILD
11 11 DR VADIVEL 60 M 164 76 120 78 301 380 7.8 55.7 5.8 2.99 0.896 9.9 2.2 1.674 0.778 13.3 5.8 0.981 0.562 MODERATE
12 12 DR RAVIDASS 53 M 165 68 110 80 307 332 9 15.9 2.7 2.348 0.833 14.1 3.2 1.454 0.771 13.9 5.1 1.126 0.63 MODERATE
13 13 DR RAKESH 18 M 160 60 120 70 252 280 7.8 42.6 4.3 3.356 0.899 17.3 3.9 1.692 0.776 8 5.2 0.432 0.355 MILD
14 14 DR SRINIVASAN 53 M 170 66 110 80 177 260 7.9 28.7 5.6 1.763 0.803 5.6 1.8 1.045 0.676 5.3 3.2 0.484 0.4 MODERATE
15 15 DR MALAR 45 F 151 72 120 84 356 446 8.5 33.2 6.1 22.87 0.815 7.1 1.6 1.416 0.778 3.7 2.6 0.332 0.316 SEVERE
16 16 DR BOMMI 64 F 154 60 110 70 215 297 8.2 18.1 3.7 1.817 0.796 8.8 ` 1.631 0.803 7.8 2 1.698 0.743 MODERATE
17 17 DR SAKUNTHALA 52 f 149 60 120 80 237 288 8 60.2 8 2.294 0.868 9.5 1.9 1.55 0.796 9.7 5.4 0.55 0.44 MODERATE
18 18 DR MUTHU 50 M 164 53 112 60 187 223 8.2 44.1 13.4 1.335 0.696 11.8 1.8 2.182 0.846 9.7 4.1 1.14 0.58 MILD
19 19 DR NIRMALA 60 F 156 60 110 80 223 360 8 44.2 8.5 2 0.808 4.2 1.5 1.013 0.65 2.3 1.5 0.426 0.362 MILD
20 20 DR NANDHINI 45 F 162 54 120 80 228 260 7.9 41.3 5 2.064 0.879 4.4 2.7 0.785 0.529 5.7 2.5 0.885 0.559 MILD
21 21 DR SOLOMAN 61 m 161 65 110 80 311 385 8.7 30.5 4.9 2.428 0.838 13.4 3.4 1.424 0.75 6.9 3.4 0.812 0.514 MODERATE
22 22 DR KAMARAJ 55 M 165 58 120 70 196 228 7.9 15.8 2.6 2.194 0.833 15.2 4.2 1.487 0.725 5.6 3.5 0.428 0.37 MILD
23 23 DR MURUGESAN 65 M 175 58 120 70 306 408 8.9 26.6 3.4 2.275 0.871 7 2.2 1.147 0.692 10.8 5.4 0.833 0.5 MILD
24 24 DR MANNAR 60 M 170 65 120 60 282 298 9.1 38.7 5.7 2.318 0.854 12.7 2.1 2.681 0.854 8.4 4.6 0.659 0.447 MODERATE
25 25 DR ANNADURAI 55 M 178 57 120 80 352 392 12.3 23 5.5 1.829 0.761 6.9 2.2 1.15 0.676 6.1 4.9 0.229 0.2 MILD
26 26 DR ANANDAN 56 M 170 65 110 80 308 382 10 33.9 8.5 1.734 0.75 11.5 1.8 2.275 0.844 9.5 6.1 0.514 0.358 MILD
27 27 DR JAYARAMAN 78 M 165 62 110 80 124 256 8.2 35.6 6.7 1.821 0.811 11.1 2.8 1.511 0.746 6.4 4.2 0.401 0.333 MILD
28 28 DR LAKSHMI 60 M 160 68 120 60 270 320 9.5 34 3.1 2.467 0.91 18.3 3.3 1.699 0.822 5.7 3.1 0.534 0.452 MODERATE
29 29 DR POONGA 60 F 164 52 118 72 302 361 8.5 32 7.4 1.603 0.769 8 2.1 1.317 0.733 5.7 3 0.732 0.469 MILD
30 30 DR SHANTHI 59 F 147 65 120 72 235 370 7.8 29.4 3.5 2.221 0.882 11.1 2 1.689 0.823 12.4 4.1 1.23 0.669 MILD
31 31 DR SAROJA 60 F 160 68 110 80 208 252 8.1 33.8 5.1 2.331 0.848 12.2 1.8 1.849 0.855 7.4 5.3 0.334 0.286 MODERATE
32 32 DR SARAVANAN 37 M 180 65 120 84 438 520 11.5 36.6 5.8 2.2 0.841 12.5 1.9 1.839 0.845 4.5 3.9 0.13 0.12 MODERATE
33 33 DR SURESH 45 M 168 62 110 80 333 386 9.2 29.2 4.6 2.313 0.841 10 2.5 1.43 0.75 11.5 3 1.8 0.738 MODERATE
34 34 DR ANNAMALAI 52 M 164 59 110 80 283 306 8.6 18.7 2.9 2.342 0.845 9.6 3.6 0.942 0.621 8 1.6 1.244 0.797 MODERATE
35 35 DR SULTHAN 68 M 168 70 110 80 364 382 9.2 27.8 8 1.521 0.713 24.1 3.3 2.898 0.857 9.4 4.4 0.944 0.538 MILD
36 36 DR SABEENA 65 F 165 65 120 70 308 356 8.9 33.5 4.2 2.103 0.874 16.6 2.6 1.788 1.864 6.9 3.7 0.679 0.461 MODERATE
37 37 DR INBARAJ 48 M 161 51 110 70 370 392 9.3 32.3 4.1 2.3 0.874 6 1.4 1.278 0.765 7.8 3 1.272 0.614 MODERATE
38 38 DR VELU 33 M 165 78 120 80 303 363 8.8 33.4 5.4 2.306 0.838 21 2.3 2.239 0.89 11.4 6.2 0.702 0.453 MILD
39 39 DR MAHIMA 45 F 162 58 110 60 246 282 9.1 17.9 4.4 1.591 0.756 10.7 3.7 1.108 0.653 8.5 4.1 0.825 0.513 MILD
40 40 DR MAHESH 50 M 160 55 110 70 263 285 8.2 29.7 6.2 1.86 0.792 17 3.9 1.483 0.771 11.1 5.2 0.973 0.527 MILD
41 41 DR ANANTHAKUMAR 58 M 168 65 120 80 320 363 7.5 36.3 6.3 1.697 0.827 14.5 2.9 1.473 0.796 7.6 3.9 0.696 0.481 MILD
42 42 DR ARIVU 60 F 169 62 110 80 263 340 7.4 23.7 5.6 1.363 0.763 14.6 1.9 1.68 0.868 10.1 3.2 1.381 0.683 MILD
43 43 DR CHANDRASEKAR 59 M 165 58 110 60 367 428 9.1 28.8 9.3 1.144 0.678 7.2 2.6 1.239 0.642 5.9 3.3 0.542 0.436 MILD
44 44 DR CHANDRA 55 F 164 60 110 70 363 394 8.9 23.9 7.9 1.132 0.671 6.5 1.5 1.633 0.771 5.3 2.9 0.586 0.456 MILD
45 45 DR SHANKARAN 60 M 198 58 120 70 326 362 8.5 19.3 2.6 1.85 0.865 4.6 1.1 1.351 0.757 6 3 0.811 0.511 MILD
46 46 DR CHANDRAN 50 M 169 60 110 80 343 382 8.4 15.8 4.7 1.611 0.704 5.6 1.6 1.264 0.714 6.9 2.7 0.89 0.6 MILD
47 47 DR DHAMODHARAN 48 M 168 59 120 80 351 376 7.9 15.8 4.7 1.611 0.704 19.4 3.2 1.735 0.833 9.5 4 0.986 0.585 MILD
48 48 DR DHANUSHKODI 50 M 168 62 110 80 303 343 7.6 16.6 3 1.735 0.82 21.9 3.9 1.671 0.821 9.7 4.4 0.885 0.548 MILD
49 49 DR GANAPATHY 55 M 170 60 120 80 243 292 7.9 57 6.9 1.845 0.88 10.7 2 1.777 0.816 11.9 4.7 0.886 0.607 MILD
50 50 DR VARUN 50 M 165 62 120 80 360 392 9.2 31.6 4.1 2.042 0.872 7.9 1.5 1.517 0.804 3.9 2.5 0.422 0.357 MILD
51 51 DR VASNATA RAJ 51 M 169 79 130 80 245 263 7.8 35.8 9.2 1.473 0.744 14.6 3.9 1.336 0.736 9.5 6.5 0.433 0.319 MILD
52 52 DR GANESAN 55 M 156 39 110 70 168 232 9 40.5 4.3 1.938 0.893 14.3 1.8 1.459 0.871 15.4 8.1 0.651 0.477 MILD
53 53 DR GANGADHARAN 60 M 160 45 120 80 170 243 9.3 42.5 4.5 1.928 0.894 12.6 1.8 1.381 0.854 12.9 5.8 0.745 0.549 MILD
54 54 DR GANDHIMATHY 50 F 165 56 110 70 260 308 7.4 30.4 2.5 1.901 0.918 14.5 1.4 2.058 0.902 15 2.8 1.075 0.811 MILD
55 55 DR KARPAGAM 50 F 164 54 120 80 246 324 7.3 48.3 4 2.209 0.918 7.4 1.2 1.774 0.835 2.5 1.5 0.533 0.398 MILD
Weight SBP DBP FBS
S. 
no.
Group AGE SEX HeightS.NO NAME PPBS HbA1C
CENTRAL RETINAL ARTERY CENTRAL RETINAL VEIN
FUNDOSCOPY
OPHTHALMIC ARTERY
 KEY TO MASTER CHART: 
SBP –SYSTOLIC BLOOD PRESSURE 
DBP-DIASTOLIC BLOOD PRESSURE 
FBS-FASTING BLOOD SUGAR 
PPBS-POST PRANDIAL BLOOD SUGAR 
DR-DIABETIC RETINOPATHY 
DNR-DIABETIC WITH NO RETINOPATHY 
ND-NON DIABETIC 
OAPSV- OPHTHALMIC ARTERY PEAK SYSTOLIC VELOCITY 
OAEDV- OPHTHALMIC ARTERY END DIASTOLIC VELOCITY 
OAPI- OPHTHALMIC ARTERY PULSATILITY INDEX 
OARI- OPHTHALMIC ARTERY RESISTIVITY INDEX 
CRAPSV-CENTRAL RETINAL ARTERY PEAK SYSTOLIC VELOCITY 
CRAEDV- CENTRAL RETINAL ARTERY END DIASTOLIC VELOCITY 
CRAPI- CENTRAL RETINAL ARTERY PULSATILITY INDEX 
CRARI- CENTRAL RETINAL ARTERY RESISTIVITY INDEX 
CRVPSV-CENTRAL RETINAL VEIN PEAK SYSTOLIC VELOCITY 
CRVEDV-CENTRAL RETINAL VEIN END DIASTOLIC VELOCITY 
CRVPI- CENTRAL RETINAL VEIN PULSATILITY INDEX 
CRVRI- CENTRAL RETINAL VEIN RESISTIVITY INDEX 
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